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Abstract
Introduction: Primary open angle glaucoma (POAG) is a potentially blinding disease
which formost of its course is asymptomatic. Raised intraocular pressure (IOP) is a risk
factor for developing glaucoma and is used to screen for at risk individuals. Up to 5% of
the population have raised IOP but only a small proportion of these ocular hypertensives
(OHT) will develop POAG. Intraocular pressure therefore performs poorly as a
screening test for glaucoma and other factors are suspected to play a role in the aetiology
of the disease.
Purpose: To compare ocular and systemic circulation and haematological factors
affecting perfusion in groups of untreated ocular hypertensives (OHT) and primary open
angle glaucoma patients (POAG) matched for IOP.
Methods: This was a prospective observational study. Twenty seven high risk OHT
(IOP>25mmHg), 24 low risk OHT (IOP<26mmHg), 24 POAG patients and 23 normal
subjects were recruited. Subjects were admitted for a morning during which the
following measurements were made; intraocular pressure, visual field assessment,
sitting, standing and supine pulsatile ocular blood flow, scanning laser Doppler retinal
blood flow and finger tip laser doppler blood flow. Venous blood was taken for the
following; full blood count, manual fibrinogen, D-dimer, prothrombin fragments F1 and
2, and beta-thromboglobulin.
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Results: Pulsatile ocular blood flow: High risk ocular hypertensives (HROHT) were
similar to POAG subjects in terms of their pulsatile ocular blood flow and both groups
had reduced POBF compared to normal. POAG had a smaller fall in POBF on lying
down than the other 3 groups. Scanning laser doppler flow: POAG had reduced blood
flow at the optic cup and increased blood flow in the temporal retina compared to
HROHT matched for IOP. Finger tip laser doppler flow: No difference in fingertip
blood flow was found between HROHT and POAG. Haematologv: A small but
significant increase in platelets and fibrinogen was seen in POAG compared to normals.
There was no difference between HROHT and POAG.
Conclusions: Ocular hypertensives with IOP above 25mmHg have levels of POBF
similar to POAG. Differences in the response of POBF to changing posture and the
distribution of blood flow in the retina in POAG compared to OHT point to a failure of
control of ocular blood flow as a possible factor in the aetiology of glaucoma.
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Abbreviations
POAG Primary Open Angle Glaucoma
NTG Normal tension glaucoma
HROHT High risk ocular hypertension
LROHT Low risk ocular hypertension
IOP Intraocular pressure
LDF Laser Doppler Flowmeter (finger tip)
POBF Pulsatile ocular blood flow
SLDF Scanning Laser Doppler Flowmeter (retina)
HRF Heidelberg Retinal Flowmeter





and Review of Literature
1.1
Introduction
The role of vascular factors in the pathogenesis of glaucoma has been a subject of debate
since the end of the 19th century. The glaucomatous optic disc was first described in the
1850's following the invention of the direct ophthalmoscope. In 1857 von Graefe
proposed what would become the mechanical theory of glaucoma pathogenesis
suggesting that optic nerve cupping arose secondary to backward pressure on the lamina
cribrosa in eyes with raised intraocular pressure (IOP)T The following year Jaeger
suggested that deficient circulation in the short posterior ciliary arteries was responsible
for glaucomatous optic atrophy^, a proposal which has become known as the vascular
theory of glaucoma damage. Over the following 100 years researchers continued to
debate the aetiology of the disease. Other risk factors were identified and it became clear
that open angle glaucoma was a disease produced by the interaction of several factors of
which intraocular pressure was one. Additional evidence that glaucoma was more than
simply a mechanical response to raised IOP was seen in the existence of a large group of
people with raised intraocular pressure who never developed glaucoma. The difficult
clinical problem of how to best manage these patients, known as ocular hypertensives,
has been a subject for discussion in recent years.
There is a wealth of published research describing changes in ocular blood flow in
glaucoma but it is difficult to determine how these changes relate to raised IOP. Is
19
reduced blood flow simply a consequence of increased pressure in the eye or is there a
primary fault in the control of both IOP and ocular circulation in open angle glaucoma?
In addition to this the results ofmany studies are difficult to interpret due to the past or
concurrent use of drugs to lower intraocular pressure in the patient groups.
The purpose of this study is to examine the ocular circulation and factors affecting it
such as clotting function and peripheral vasoreactivity in glaucoma patients using ocular
hypertensive subjects as a comparison group. This allows the groups to be matched for
IOP exposing any differences in blood flow which may be attributed to the presence of
disease. It may also provide information about ocular hypertension which could help to
answer questions about the most appropriate way to manage people with raised
intraocular pressure.
Section I reviews the literature relating to primary open angle glaucoma and ocular
hypertension. The epidemiology of both is outlined. The literature relating to intraocular
pressure and its value as a predictor of POAG is reviewed and normal ocular circulation
is described. This is followed by a summary of investigations into other risk factors for
glaucoma and OHT with emphasis on vascular factors, broadly divided into ocular blood
flow measurement, peripheral vascular reactivity and haematological investigations.
Section II outlines the study protocol and subject recruitment Results of the study are




Definition: Primary open angle glaucoma is an optic neuropathy with characteristic
visual field loss and optic disc changes usually associated with raised intra ocular
pressure.
Glaucoma is the name given to a collection of diseases which together represent one of
the most important causes of blindness and visual impairment in the Western world 3.
Evans in 1995 stated that glaucoma was the second most prevalent cause of registered
blindness in the UK after age related macular degeneration, accounting for 12% of
registrations^, and Quigley in 1996 estimated that 66.8million people world-wide would
suffer from glaucoma by the year 2000, 6.7 million of those being bilaterally blind^.
Glaucoma can be broadly classified as chronic or acute. Primary open angle glaucoma
(POAG) is the most prevalent form of chronic glaucoma. Diagnosis of POAG is based
on the presence of raised intraocular pressure (IOP), cupping of the optic disc (figure 1)
and characteristic visual field loss in an arcuate pattern between 10 and 20 degrees of
fixation (figure 2) in the presence of open drainage angles. However, approximately 1/3
of chronic glaucoma patients have intraocular pressure within the normal range This
variant of the disease is known as normal tension glaucoma (NTG).
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Figure 1: Colour photographs of the optic disc:
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Figure 2: Glaucomatous visual field loss
(Humphrey visual field analyser program 24-2)
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A small proportion of chronic glaucomas are due to congenital abnormalities in the
structure of the eye or occur secondary to damage to or blockage of the trabecular
meshwork (angle recession, pigment dispersion, pseudoexfoliation, uveitis and chronic
angle closure). In the initial stages of the disease chronic open angle glaucoma is almost
invariably asymptomatic and population studies estimate that less than 50% of those
with glaucomatous field loss have received an appropriate diagnosis or treatment^JO
The work reported here relates to patients with primary open angle glaucoma.
Structural changes identified in the glaucomatous eye include optic disc cupping with
posteriormovement of the lamina cribrosa and loss of axons at the optic nerve head, a
decreased photoreceptor count over the entire retina and loss of RPE cells particularly in
the peripapillary area H. In postmortem glaucoma eyes Quigley et al found preservation
of normal capillaries and astrocytic glial cells at the optic nerve head. He concluded that
structural weakness in the lamina cribrosa was the primary problem in POAG leading to
impaired axonal transport in the presence of raised IOPl^. In contrast to Quigley's
finding of no vascular changes at the glaucomatous optic disc, a study by Kubota et al in
1993 identified significant choroidal thinning with reduced choroidal vessel diameter
most marked at the optic disc border in enucleated eyes with chronic angle closure
glaucoma secondary to malignant ciliary body melanoma. The control group comprised
enucleated eyes with choroidal melanoma and normal intraocular pressure
24
Studies looking at the prevalence of chronic glaucoma (Table 1) have given fairly
consistent results although in the past a clear distinction has not always been made
between ocular hypertension (raised pressure in a healthy eye) and glaucoma. The
prevalence of primary open angle glaucoma and normal tension glaucoma combined is
approximately 2% in Caucasian populations over the age of 40.

































































KEY: VFD = visual field defect
ODC = optic disc cupping
VCDR = vertical cup/disc ratio
NTG = normal tension glaucoma
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It has been shown that the prevalence of POAG increases with age 7,19,20 The
Framingham study found an increased incidence inmen^ although other studies have
found no gender difference^. Chronic open angle glaucoma has also been found to be
significantly more common in blacks than in Caucasians^. There is a higher incidence
of POAG among diabetics than in the general population^,23 Some studies have found
an association between POAG and myopia 24 an(j aiso between POAG and higher
systolic blood pressure^. The use of these associations to help to identify OHT patients
at risk of progressing to POAG is common in clinical practice and has been addressed
recently in the Ocular Hypertension Treatment Study26 which is covered in more detail




Definition: Intraocular pressure consistently raised above 21mmHg in a healthy eye with
full visual fields, normal optic disc appearance and open drainage angles.
The distribution of IOP in the general population is not normal but is skewed to the right
with a preponderance of higher IOPs (figure 3).
8 10 12 14 16 18 20 22 24 26 28 30 32 36
IOP mmHg
Figure 3: Distribution of IQP in the population
Data taken from right eyes of 4297 subjects, Bonomi et al14
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The concept of raised IOP has arisen from a desire to identify individuals at the greatest
risk of developing glaucoma. It has been established that high IOP has a strong positive
association with glaucoma risk, the higher the pressure the higher the risk 8,27,28_ jn the
past it was felt the most effective way to identify future glaucoma patients was to
concentrate on those members of the population with IOPs in excess of two standard
deviations above the population mean. According to the known distribution of pressures
this group of people will have an IOP of over 21 mmHg. Thus the pressure of 21mmHg
has become the level above which people are labelled 'ocular hypertensive' and are
assumed to be at increased risk of glaucoma.
Studies have shown that approximately 5% of the population have an IOP of over
21mmHg29 although this proportion changes with age and may also be affected by
race 17. Only a small proportion of ocular hypertensives develop glaucoma. Longterm
follow-up of cohorts of ocular hypertensives has given varying results but the majority
of studies put the incidence of conversion to glaucoma at about 2% per year (Table 2).
28
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f Cumulative probability over 5 years
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Problems have arisen in clinical studies because there is no consensus of opinion on the
diagnostic criteria for glaucoma and ocular hypertension, in addition because the
conversion rate is low large cohorts of ocular hypertensives must be followed up for
many years to obtain accurate data. As seen in table 2 there has often been no agreement
between studies as to what constitutes progression to glaucoma. The Ocular
Hypertension Treatment Study (OHTTS)^ ran from 1994 to 1999 with the aim of
addressing these problems. The major finding of the study was that treatment of 'higher
risk' ocular hypertensives (with IOP of 24-32mmHg) producing a 20% fall in IOP
reduced the risk of conversion to glaucoma from 9.5% to 4.4% over 5 years. Conversion
to glaucoma was defined as development of reproducible field loss or optic disc
deterioration.
Visual field assessment
Many methods have been devised for assessing visual fields. Visual field testing is one
of the mainstays of glaucoma screening and characteristic deterioration in visual field is
generally taken to indicate conversion from OHT to glaucoma. There are recognised
difficulties in obtaining reliable and reproducible results from a group of patients many
of whom are elderly and have coexistent eye disease that may interfere with visual
acuity. Recent advances in automated perimetry have produced tests that are quicker and
easier for patients to perform such as the Swedish Interactive Threshold Algorithm
(SITA fast) and Frequency Doubling Technology (FDT). ShortWavelength Automated
Perimetry (SWAP) may identify very early glaucomatous damage and have some
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predictive value in glaucoma screening and the multifocal electroretinogram (mfERG)
can provide an objective measurement of the visual field although it is not commonly
used in routine screening 35. Large, multicentre studies such as the OHTTS and the
Advanced Glaucoma Intervention Study (AGIS) have devised methods for assessing
field progression as measured with automated perimetry with the aim of achieving better
reliability and objectivity 36. A recent paper by Vesti et al reviewed seven such methods
and found that those with high specificity such as that used by AGIS had lower
sensitivity and classed fewer cases as having progressed than the other methods
reviewed 37.
Clinical importance of ocular hypertension
One of the difficult problems in glaucoma management is how best to look after ocular
hypertensives. It is known that two thirds of glaucoma patients are in this group but that
only a small proportion of ocular hypertensives will develop the disease. Raised IOP
continues to be used as the main indicator of future glaucoma risk and IOP is targeted by
all current treatment methods. Many studies have pointed out the inefficiency of
tonometry as a screening measurement 7,15,38 confirming that although IOP has a
strong positive association with glaucoma 8,28 for m0st patients it is a poor predictor of
disease.
Until the publication of the findings of the Ocular Hypertension Treatment Study there
was no clear evidence that reducing IOP held any benefit in preventing glaucoma. In
addition to this important finding the OHTTS confirmed an association of several
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baseline factors with a higher risk of developing POAG in ocular hypertension^. On
univariate analysis older age, African race, male sex, heart disease, and thinner central
corneal measurement were all associated with a higher risk of conversion to POAG in
addition to larger vertical or horizontal cup to disc ratio, higher IOP and areas of reduced
sensitivity (greater CPSD) on visual field testing. However the best predictors of
conversion as identified with multivariate analysis were baseline age, cup to disc ratio,
pattern standard deviation on field testing and high intraocular pressure. Central corneal
thickness was found to be a powerful predictor of POAG, a thinner cornea being
associated with higher risk. The authors postulate that corneal thickness influences IOP
measurement and patients with thicker corneas have a true IOP lower than the measured
IOp26 Subgroups of OHT patients were identified with a significantly higher risk of
progression than the 0.5% to 1% risk found by the study overall. Baseline IOP of over
25.75mmHg combined with a thin cornea (<556pm) carried a 36% risk of conversion
over 5 years, whilst a cup to disc ratio of over 0.3 combined with a thin cornea was
associated with a 24% risk.
Despite this significant advance in our understanding of the clinical history of ocular
hypertension and risk factors for progression to glaucoma, treatment of the high risk
groups as defined by the OHTTS would still result in the majority of patients receiving
unnecessary treatment for at least 5 years. This emphasises the fact that our knowledge
of the underlying factors producing glaucoma is far from complete and that there is still





There follows a review of the literature relating to intraocular pressure with respect to
visual function and glaucoma and the effects of drugs designed to lower it.
Intraocular pressure is the most universally used indicator of glaucoma risk. As stated
previously the traditional assumption that raised pressure is the primary cause of
glaucoma is controversial. The majority of ophthalmologists will decide whether to treat
a patient with raised intraocular pressure based on the level of IOP in the context of the
person's age, family history and other ophthalmic findings.
Intraocular pressure is known to vary naturally with time. Several studies have examined
this tendency both in populations and in cohorts of patients. Schwartz and Talusan 40
looked at spontaneous trends in IOP in a group of untreated ocular hypertensives with
IOP>21mmHg over 3-4 years. They found that the majority of ocular hypertensives had
stable IOP as did a group of normal controls. A proportion (13%) of OHTs had a slight
increase in IOP over time. Thirty seven percent of OHTs also showed cyclical changes
in pressure over 1 to 2 year periods. On average the total population showed a small
decrease in IOP over time, and they suggest that the group of OHTs showing a tendency
to increasing IOP may be the group that go on to develop glaucoma. They do not
provide longterm evidence to support this theory however and none of their subjects
developed field loss during the course of the study. Linner 41 found a slight decrease in
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IOP when following a group of ocular hypertensives with IOP 21-25mmHg for 10
years. He postulates that this fall is secondary to reduced aqueous production by the
ageing ciliary body. Sorensen et al^2 followed a group of 39 untreated ocular
hypertensives for 15 years and found 20 had reduced IOP over time while the remainder
had stable IOP. None of this group developed field loss. Shiose 43 reported on a very
large population study in Japan in which 192,138 people were examined over a period of
10 years. It is not clear from the report whether any of the subjects had more than one
visit during the period of the study but the data appears to cross sectional rather than
longitudinal in nature. A lower average IOP was found in older age groups compared to
younger subjects. It was found that the presence of obesity and hypertension were
positively associated with higher IOP and that the prevalence of both was increased in
the older subjects but not to the same extent as in aWestern population. This possible
confounding effect of systemic factors may explain the conflicting results found by
longitudinal studies performed on small groups of selected patients and cross-sectional
population studies in the West.
Intraocular pressure has also been found to change in individuals in a cyclical fashion in
relation to the seasons, the highest IOP being found in winter. This is a finding which is
difficult to explain but it has been confirmed by different observers^,44,45# It has also
been recognised for many years that IOP shows diurnal variation in the healthy eye with
highest pressures present in the mornings 4b. Glaucoma patients47 and high myopes48
have been found to have patterns of IOP throughout the day and night which differ
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significantly from those recorded in normals. Liu et al measured IOP in newly diagnosed
glaucoma patients and normal controls. They found that in addition to higher diurnal
IOP glaucoma patients showed a smaller increase in nocturnal (supine) IOP and an
increase in IOP on wakening which was not seen in normals 47.
The response of IOP to changing position has also been investigated. Most reports
identify an increase in IOP in normal subjects on changing position from sitting to
supine49-51 Linder et al investigated the effect of inverted body position on IOP in
normal subjects^. They found that placing a subject in positions ranging from supine
(0°) to upside down (-90°) produced very significant increases in IOP of up to three
times baseline level. Associated with this increase was a reduction in visual function as
assessed by pattern reversal ERG and VEP. The authors propose a reduction in ganglion
cell function associated with head down posture as an explanation for their findings.
Many studies have identified a larger postural change in IOP (increase on lying down) in
some conditions including primary open angle glaucoma^®'^, ocular hypertension^,
normal tension glaucoma^} and non arteritic anterior ischaemic optic neuropathy^'.
In an interesting study by Schuman and associates^ an increase in IOP was identified in
musicians playing high resistance wind instruments associated with a transient increase
in uveal thickness as measured with ultrasound biomicroscopy. The magnitude of IOP
rise was dependant on the resistance provided by the particular instrument. High
resistance wind instrument players had a small but significantly greater incidence of
visual field defects than other musicians which was related to life hours of playing. This
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suggests that even healthy eyes when repeatedly subjected to large variations in IOP
may suffer loss of visual function.
There is little doubt that very high levels of IOP produce optic nerve damage. This has
been demonstrated experimentally in primates ^6 an(j also in humans. Drance performed
clinical experiments with people on whom a suction cup was used to temporarily
increase IOP. Characteristic scotomata developed in Bjerrum's area with elevated IOP
and those with established POAG developed field abnormalities at lower levels of IOP
than normal subjects^.
It is clear from the preceding studies that while raised intraocular pressure plays an
important role in the development of glaucoma there are physiological influences on
IOP including age, the time of day and the time of year which may make the task of
obtaining a meaningful measurement in an individual at a given time quite difficult.
The effect of short term reduction in IOP
Current treatment of glaucoma is aimed at lowering the intraocular pressure.
A number of studies have looked at the effect of an experimental reduction in IOP on
visual function. Flammer and Drance looked at the effect of lowering IOP by
administering oral acetazolamide to 9 patients with POAG and 16 with OHT. The mean
pre-treatment pressure was 25mmHg in both groups and a mean reduction of 8mmHg
was achieved, a small reduction in blood pressure also occurred. A significant
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improvement in visual field in POAG subjects was found on automated testing. There
was no change in the OHT group. The degree of improvement in visual field did not
correlate with the magnitude of pressure reduction and they suggest that improvement
produced by acetazolamide may be due to an acidosis-induced increase in choroidal
blood flow58. Other investigators have also found an improvement in visual field after
acetazolamide59. The effect of other IOP reducing medications has been explored in the
acute situation . Flammer and Drance^ used a masked randomised study to compare
the effects of topical pindolol with placebo. They found no significant effect on visual
fields with either preparation. They also looked at the effect of epinephrine and timolol
and found a small nonsignificant reduction in visual field after both. Several factors
must be taken into account when considering the above studies. Bias in both patient and
observer is a potential problem particularly when manual perimetry is used. Learning
effects producing improvement over time may also confound results. Flammer and
Drance used experienced patients in their study in an attempt to reduce this effect.
Effect of longterm reduction in IOP
The effect of longterm reduction in IOP has been investigated in the context of
glaucoma and glaucoma risk. Progression of visual field loss, and in some cases an
increase in optic nerve head cupping and pallor is taken to indicate failure of treatment.
Problems with compliance and long term follow-up particularly in ocular hypertensives
can blur the distinction between failure of treatment to prevent glaucoma and failure of
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treatment to lower IOP. Reports in the literature in the past have given conflicting
results. Some have found no benefit in reducing the IOP in ocular hypertensives 28.32,
Other studies have found that lowering the IOP in ocular hypertension reduces the
incidence of progression to glaucoma 33,34,61, jn m0st of these studies numbers were
small and problems were encountered with poor compliance and high dropout rates
among ocular hypertensives. The recently published findings of the ocular hypertension
treatment study add considerable weight to the view that lowering the intraocular
pressure in ocular hypertension reduces the risk of progressive optic disc damage and
visual field loss26.
At the outset of this study the benefit of reducing IOP in established glaucoma had still
not been definitely confirmed. Prospective randomised trials of treatment vs. no
treatment were difficult to justify for ethical reasons and were therefore non-existent.
The recent publication of the findings of two important studies has added greatly to our
understanding of the role of IOP in disease progression. The Advanced Glaucoma
Intervention Study provides good evidence that visual field loss in eyes with lower
intraocular pressure progresses significantly more slowly62. in addition the Early
Manifest Glaucoma Trial found that the risk of progressive visual field loss is closely
linked to reduction of IOP, subjects treated with argon laser trabeculoplasty and
betaxolol having half the risk of progression of control patients in the study^3.
As the preceding review demonstrates the relationship between IOP and glaucoma is not
straightforward. There is a definite link between increased levels of IOP and risk of
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developing open angle glaucoma but for levels below 30 mmHg a clear causal
relationship has not been proved. In addition the reduction of IOP in both ocular
hypertension and established glaucoma has been shown to have a beneficial effect on
visual field preservation. There is a natural tendency for IOP to vary with time in an
individual and the physiological mechanisms governing this are not well understood.
These facts contribute to the poor performance of IOP as a screening test for glaucoma
as confirmed by clinical studies that find while raised IOP is a significant risk factor for
the development of glaucoma it is a poor predictor of disease 28,30,31 when IOP is
used to detect the population at risk of developing glaucoma the group labelled 'ocular
hypertensive' is produced. This group which comprises approximately 5% of the
population contains only a small number who will go on to develop glaucoma. The
search for better markers of the pre-glaucomatous state has continued in the hope that





Two separate vascular systems supply the eye; the retinal circulation and the choroidal
circulation. Both are derived from the ophthalmic artery, the first branch of the internal
carotid. Within the orbit the ophthalmic artery divides into the central retinal artery,
between 1 and 5 posterior ciliary arteries and several anterior ciliary arteries (figure 4).
The central retinal artery enters the optic nerve 10 to 15mm behind the globe and lies
beside the central retinal vein in the anterior nerve before emerging into the fundus
where its branches lie within the nerve fibre layer and supply the inner 2/3 of the retina.
Retinal circulation accounts for 5 to 10% of total ocular blood flow.
The ciliary vessels divide into 10 to 20 short posterior ciliary arteries (SPCAs) which
enter the posterior globe and in many cases contribute to an anastomotic circle around
the optic nerve called the circle of Zinn-Haller. Two long posterior ciliary arteries pass
anteriorly to supply the anterior portion of the globe. The SPCAs empty into the choroid
which supplies the outer retinal layers including the photoreceptors. Choroidal blood
flow is of major importance in supplying nutrients to the retina, up to 95% of the total
volume of ocular blood flow is through the choroid and in animal studies 65% of the O2
required by the retina comes from choroidal blood.
40
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LPCA = Long Posterior Ciliary Artery
SPCA = Short Posterior Ciliary Artery
PCA = Posterior Ciliary Artery
CRA = Central Retinal Artery
Figure 4: Branches of the Ophthalmic Artery
(adapted from Grants Atlas of Anatomy 9th Edition64)
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The head of the optic nerve can be divided into 4 distinct anatomical areas. The
superficial nerve fibre layer is supplied by branches of the central retinal artery. The
prelaminar area and the lamina cribrosa are supplied by branches of the short posterior
ciliary arteries often via the circle of Zinn Haller^. The retrolaminar region is supplied
by the central retinal artery and the pial network of vessels^ (Figure 5). A study by
Anderson in 1974 using monkeys found very little damage to the optic nerve after
occlusion of the short posterior ciliary arteries demonstrating the presence of a very
effective anastomosis with the pial vessels via the circle of Zinn Haller. He cautions
against the assumption that optic nerve head blood flow behaves in the same way as that

















Figure 5: Blood SuppIv of the Optic Nerve Head
(adapted from Snell68 and Harris66)
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Physiological controls on ocular blood flow
The ocular perfusion pressure (OPP) is the local arterial blood pressure in the vessels
entering the eye. This is calculated as 2/3 ofmean arterial pressure (MAP) in a seated
subject due to the elevated position of the eye relative to the heart, minus the intraocular
pressure (IOP).
OPP = 2/3 MAP-IOP69
Both local and systemic factors act to maintain optimal perfusion of the tissues by
alterations in vessel diameter. The terminology in the literature relating to this of type of
blood flow modulation is confusing. For the purpose of this review autoregulation is
taken to mean a change in local vascular resistance or arteriolar calibre occurring in
response to an alteration in either local or systemic requirements. The local changes in
blood vessel diameter may be mediated by three mechanisms; myogenic, neurogenic or
metabolic. Vascular smooth muscle may respond to stretch or to factors released by the
vascular endothelium (myogenic). Changes may occur in response to local levels of
pC>2, pCC>2 and pH (metabolic), and blood flow distribution may also be altered by the
autonomic nervous system (neurogenic). The relative importance of these different
influences on ocular blood flow has been investigated.
The autonomic nerve supply to the eye is distributed only within the uvea and the extra
ocular parts of the retinal vessels. Parasympathetic vasodilator nerves secreting VIP and
sympathetic areceptors have been found in the choroid suggesting that autonomic input
may play a part in the regulation of choroidal flow.
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Stjernschantz et al investigated intracranial stimulation of the oculomotor nerve
(containing parasympathetic fibres) in rabbits. They found that it produced sustained
choroidal vasodilation in addition to a transient vasoconstriction in the iris and ciliary
body and pupil miosis. The effect on the anterior uvea was potentiated by inhibition of
prostaglandin synthesis with indomethacin. 70
Michelson et al documented alterations in ocular blood flow associated with exercise
induced changes in blood pressure in humans. Using transcranial Doppler and laser
Doppler flowmetry they demonstrated an increase in vascular resistance of the branches
of the ophthalmic artery and the iris vessels associated with an increase in blood
pressure. The blood velocity in these vessels was unaffected and they conclude that a
sympathetic mechanism exists which protects the eye from overperfusion in a 'fight or
flight' situational
A disturbance in autonomic function has been suggested in the past as a possible
etiological factor in glaucoma^^. However investigation of autonomic function in
glaucoma patients has not been extensively reported in the literature. In 2002 Brown and
associates noted impaired cardiovascular responses to baroreflex stimulation using
sinusoidal neck suction in open angle and normal pressure glaucoma patients73.
Kashiwagi et al reported a disturbance in the circadian rhythm of the autonomic nervous
system in glaucoma as measured with ambulatory electrocardiography over 48 hours74
These very recent studies may herald a resurgence of interest in the autonomic system in
relation to glaucoma.
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Studies investigating autoregulation in glaucoma
Animal studies have produced evidence of efficient autoregulation in the retina but
conflicting results regarding the optic nerve head. The mechanism is assumed to be
metabolic or myogenic as autonomic nerves have not been found in the retina. Aim and
Bill, using monkeys, found that choroidal and retrolaminar blood flow reduced by 30%
in eyes exposed to an experimental increase in IOP while retinal blood flow remained
unchanged 75. The blood vessels at the optic nerve head resemble retinal and central
nervous system capillaries and it is reasonable to assume that they could show
autoregulation in a similar way. Quigley et al using tritiated iodopyrine in monkeys
found no alteration in optic nerve head blood flow in response to raised intraocular
pressure 76. Bill and Sperber used the deoxyglucose method in monkeys and found that
inner retinal blood flow increased in response to flicker light while choroidal flow
remained unchanged 77. Anderson suggested in 1974 that at normal intraocular
pressures choroidal circulation is far in excess of requirements. Alterations in choroidal
perfusion secondary to raised IOP can therefore be accommodated by the eye without
loss of function. The retinal circulation in contrast is more exactly matched to the local
needs of the tissue and therefore displays greater constancy due to autoregulation 67.
Pillunat presented evidence to support the presence of autoregulation in human eyes.
Intraocular pressure was increased using a suction cup in glaucoma subjects and in
normal controls. Retinal and ciliary perfusion pressure were measured with
oculooscillodynamography. Visual evoked potential (YEP) was recorded at each
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increase in pressure. The results demonstrated a plateau phase in the reduction of VEP
with increasing IOP in the graphs produced by normals which was not present in POAG
patients. The authors suggest that this finding supports the existence of autoregulatory
mechanisms governing blood flow at the optic nerve head which are reduced or absent
in glaucoma^.
Grunwald et al used the blue field eutopic phenomenon (BFE), which allows a subject to
see leukocytes moving in their own macular capillaries, and a suction cup to artificially
increase intraocular pressure. They found that POAG patients could not maintain their
retinal circulation when mean IOP was over 24.2mmHg whereas normal and OHT
subjects could maintain perfusion to much higher levels of IOP (30.8mmHg and
29.9mmHg respectively). After reduction of IOP back to resting levels OHT and normal
subjects showed a hyperaemic response suggesting that vasodilation had occurred during
the period of increased IOP. This hyperaemia was not present in POAG. In this study
both POAG and OHT subjects were using topical treatment to lower the IOP and more
POAG subjects than OHTs were on timoptol (7 and 1 respectively) which may well
have affected the results 72 .
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Visual Function and Blood Flow
Some studies have identified changes in visual function associated with alterations in
blood flow.
Paris et al found a significant improvement in contrast sensitivity in normal adults after
taking sildenafil associated with a 30% increase in pulsatile ocular blood flow and no
change in intraocular pressure 79.
Ginko biloba extract (GBE) has been found to increase end diastolic velocity in the
ophthalmic artery on CDI without changing IOP, systemic blood pressure or pulse rate
80. It is known to reduce vasospasm, and serum viscosity in addition to having an
inhibitory effect on apoptosis and platelet activation 81. Quaranta gave GBE to normal
tension glaucoma patients in a double blind cross-over study and found a significant
improvement in visual field performance (MD and CPSD, p<0.0001). No change in IOP,




in Glaucoma and Ocular Hypertension
A. Pulsatile Ocular Blood Flow
Continuous measurement of intraocular pressure reveals a pulsatile variation
synchronous with the systemic pulse (figure 6). It is possible to calculate the volume of
blood responsible for the pressure increase during each cardiac systole using a formula
derived from experimental data (see chapter 2.2). This calculated change in volume over
time is known as the pulsatile ocular blood flow (POBF) and is expressed in microlitres
per minute. Because choroidal filling is thought to account for 85 to 90% of the ocular
pulse volume POBF is taken as an indirect measure of choroidal blood flow.
Several assumptions are made in the calculation of POBF. Most importantly it is
assumed that outflow from the eye is constant, that there is no reflux and that the
pressure-volume relationship (ocular rigidity) derived from Langhams living eye
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Figure 6: POBF Machine printout
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Colour Doppler studies have measured diastolic blood flow in the ophthalmic artery
which increases in the supine position. This suggests the presence of non pulsatile
component to ocular blood flow 84. Measurement of POBF gives no information about
this non-pulsatile component of ocular perfusion and the ratio of pulsatile to non¬
pulsatile flow which may be altered in an individual by changes in heart rate or ocular
perfusion pressure.
There have been numerous studies looking at pulsatile ocular blood flow in glaucoma
and ocular hypertension over the last twenty years. The results of these studies can be
difficult to interpret due to variations in diagnostic criteria for POAG and OHT and the
frequent presence of topical treatment. However, many studies have identified a
reduction in POBF in glaucoma patients compared to normal subjects. There is less
agreement in the literature regarding findings in OHT.
In 1981 E.S. Perkins recorded the cyclical changes in IOP with an adapted Goldman
tonometer. He found increased pulse amplitude in OHT and POAG subjects compared to
normal. Ocular hypertensives were found to have higher pulse amplitude than POAG
patients. Pulse amplitude was also affected by refractive error being lower in myopia 85.
In 1987 Nicastro et al compared groups matched for heart rate, systemic pulse pressure
and arterial pressure. They found that ocular hypertensives had higher pulse amplitude
than either normals or POAG patients but, in contrast to Perkins, they found that POAG
patients had lower pulse amplitude than normals 86.
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The device used by Perkins was adapted by Langham to produce a pneumotonometer 87
88 Subsequent studies have used this device and more recently its descendant developed
by OBF Labs UK Ltd 89 for calculation of pulsatile ocular blood flow.
Fontana et al looked at POBF measurements from a group of 777 normal subjects. They
found mean values of 886[xl/min for females (mean age 53) and 731p.l/min for males
(mean age 54)90. Yang et al found similar normal values and calculated a reliability
coefficient of 0.92 for the measurements produced by the machine91. Trew and Smith
used the Langham OBF system to look at the effect of posture in untreated OHT subjects
compared to normals^. They found that POBF fell significantly in both groups on lying
down and was accompanied by a rise in IOP which was more marked in OHT. They also
found increased pulse amplitude in ocular hypertensives in the supine position but no
significant difference in POBF between the groups in either position. The mean IOP of
the OHTs in this study was only 22.7mmHg. In a second paper comparing treated
POAG patients on timoptol with OHT the same authors found reduced pulse amplitude
(pxO.Ol) and POBF (p<0.05) in POAG. Both groups had a significant fall in POBF
associated with a rise in IOP on lying down. Treatment was withdrawn from POAG
subjects for 2 weeks resulting in a significant increase in IOP (from 18.8mmHg to
23.2mmHg) but no change occurred in POBF or in the postural response compared to
the treated phase of the study. The authors conclude that POBF is reduced in glaucoma
compared to ocular hypertension and that it is not increased by the use of timoptol^.
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There have been some studies examining the influence of other factors on POBF. James
et al 94 found that POBF decreases with increasing axial length most probably due to the
increased volume ofmyopic eyes, a finding confirmed by others95. Ravalico reported a
reduction in POBF and pulse amplitude (PA) with age, the relationship being more
marked in subjects over the age of 50 and in the supine position^".
The influence of IOP on POBF has also been explored, James et al 94 found no
relationship between IOP and POBF in a group of 34 normal subjects, a finding
confirmed by Yang with a group of 163 normals 91 However Massey and O'Brien
found a strong correlation (p<0.001) between IOP and POBF in their study of 664
normal subjects95.
53
B. Scanning Laser Doppler Flowmetry
A relatively new method of measuring retinal blood flow was developed shortly before
this study began. Scanning laser Doppler flowmetry (SLDF) quantifies blood flow to the
superficial layers of the optic nerve head and retina 97,98 metjj0(j combines laser
Doppler flowmetry with a scanning laser system to produce pictures of the area under
investigation. The image produced is a two dimensional map of the retina with 256x64
points representing retinal perfusion which yields information about 'flow', 'velocity',
and 'volume' of red cells within a selected 'region of interest'. Further details of this
method can be found in Section 2.2.
Michelson and associates^ compared patients with primary open angle glaucoma with
normal subjects and found reduced blood flow at the lamina cribrosa and nasal and
temporal retina in the glaucoma patients. Nicolela and associates 10® using scanning
laser Doppler flowmetry also found reduced blood flow at the lamina cribrosa and
temporal retina in POAG compared to normals. The subjects in Nicolela's study were a
heterogeneous group that included normal tension glaucoma patients, two thirds of the
group were also using antiglaucoma medication .
Groh et al used SLDF to investigate changes in retinal and optic nerve head blood flow
with age. They found a significant reduction in retinal microcirculation of 6-11% per
decade in normal subjects. They did not detect any age related changes in optic nerve
head blood flowlOl. At the time of the investigation reported here there were no
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published studies looking at retinal blood flow measured with SLDF in ocular
hypertension.
N(K> s 141 183
N< 62- 129> s 2 812
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FIm = 186.78 t 128.88riw = 677.94 t 667.24
Normal optic disc Glaucomatous optic disc
Figure 7: Images of the optic disc taken with the Heidelberg Retinal Flowmeter
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C. Colour Doppler imaging
Colour Doppler ultrasound imaging (CDI) is a noninvasive technique that has been used
to examine the pulsatile blood velocity profiles in various blood vessels in the orbit
including the ophthalmic artery, central retinal artery and vein, posterior ciliary arteries
and the orbital veins. The technique uses simultaneous B-scan ultrasound and colour
Doppler imaging to locate and investigate the blood vessels. The resolution of the
ultrasound prevents accurate measurement of vessel diameter therefore the volume of
blood flow cannot be calculated with this method. Pulsed Doppler sonography is a
slightly different method which allows velocity measurements to be made at defined
tissue depths. Pulsatile ocular blood flow measurement has been found to correlate most
strongly with the CDI parameter peak systolic velocity (PSV) in the central retinal
artery
Investigation of glaucoma patients using this method has consistently found reduced
flow velocities in the ophthalmic artery compared to normal subjects.
Rojanapongpun et al measured supine ophthalmic artery flow velocities with 2MHz
pulsed Doppler ultrasound in 60 POAG, 42 NTG and 35 normal subjects. They found
significantly reduced peak, mean and diastolic flow velocities in both glaucoma groups
compared to normals, to a greater extent in NTG. The authors address the possible
confounding effect of treatment in the NTG group and conclude that the use of topical or
systemic treatment by half the patients did not affect their results. No comment is made
about the use of topical treatment or previous surgery in the POAG groupie.
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Michelson confirmed these findings in advanced treated glaucoma reporting increased
vascular resistance and reduced blood flow velocity in the ophthalmic artery compared
to normals 1^4.
Nicolela et al compared subjects with ocular hypertension and open angle glaucoma and
examined blood flow velocities and resistance in the central retinal artery, temporal short
posterior ciliary artery, and the ophthalmic artery. They found reduced peak systolic
velocity and end diastolic velocity in the central retinal artery in POAG compared to
ocular hypertensives. There were no differences found in the ophthalmic artery.
However several of their subjects were using topical betablockers and though matched
for highest recorded IOP the groups were not matched for IOP at the time of
investigation, the OHT group having the higher pressure105
Butt et al examined groups of untreated POAG, NTG and normals using CDI. They
found an increased resistance to blood flow in the central retinal artery and ophthalmic
artery and increased peak systolic velocity (PSV) in the ophthalmic artery of patients
with POAG compared to normals. Ophthalmic artery PSV was related to intraocular
pressure but there was significantly more vascular disease and higher systolic blood
pressure in the POAG subjects compared to the normal groupie which may have
explained the unexpected finding of higher PSV in glaucoma.
Williamson et al examined 95 healthy volunteers to determine the effect of age, systemic
blood pressure, smoking and blood viscosity on orbital blood velocities as measured
with CDI. They found that systolic blood pressure correlated with peak systolic velocity,
smoking was associated with lower velocities, higher haematocrit and viscosity
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correlated with increased resistance to flow proximal to the ophthalmic artery and red
cell rigidity negatively correlated with pulsatility of flow in the retinal vein. Increasing
age was associated with reduced blood velocity in the ophthalmic artery and increased
resistance to flow in the retinal circulation 107. Rojanapongpun also found a decrease in
ophthalmic artery velocities with increasing age!08 Harris et al used CDI to investigate
the effect of acute IOP elevation in healthy eyes. They found no change in ophthalmic
artery blood flow up to an IOP of 45mmHg but central retinal artery velocities were
highly IOP dependant 109.
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D. Fluorescein Angiography
Fluorescein angiography is the mainstay of ocular vascular investigation in the clinical
setting. It has also been widely used in research and various methods have been
developed to gather additional information about retinal and choroidal circulation from
the images. The time taken for the dye to pass from a retinal arteriole to a venule may be
measured using dye dilution curves and this information gives an indication of the
arteriovenous passage time in the retina. Scanning laser ophthalmoscopy combined with
fluorescein angiography enables measurement of arm-retina time, arteriovenous passage
time and mean dye velocity. The pattern of flow in the choriocapillaris may also be
observed using videoangiography or indocyanine green (ICG) angiography.
Wolf et al used SLO combined with fluorescein angiography to examine 51 patients
with POAG. They found an 11% reduction in mean dye velocity and 41% prolongation
of arteriovenous passage time in POAG compared to normalsHO. Schwartz et al found
that with increasing age there was a reduction in the rate of filling of retinal arterioles at
the optic disc and peripapillary choroid. In addition higher diastolic blood pressure was
associated with slower filling of the peripapillary choroid. In normal and OHT eyes as
systemic pulse pressure increased less time was needed to fill the retinal veins due to a
presumed faster intraretinal transit time. This pattern was reversed in POAG with a
longer filling time for the retinal veins associated with higher pulse pressure. Comparing
OHT with POAG the same study reported significantly slower rates of filling of the
retinal arteries and peripapillary choroid in OHT. The use ofmedication in these patients
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is not discussed however the median IOP of 20mmHg for POAG and 22mmHg for OHT
suggests that the patients in this study were on treatment^.
Best and Toyofuku investigated circulatory changes in response to artificial elevation of
IOP with a suction cup in normal eyes. They found that small elevations of IOP (up to
40mmHg) produced more effect on choroidal than on retinal circulation. The velocity of
blood flow was reduced in both choroid and retina but fluorescein appearance time was
delayed to a greater extent in the choroidH2.
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E. Blue Field Entopic Phenomenon
This method utilises the fact that it is possible for a subject to see leukocytes moving
within their own paramacular retinal capillaries when looking at a diffuse blue light. A
blue light of wavelength 430nm is presented to one eye and white cells are seen as
multiple comma shaped flecks crossing the paracentral visual field. The density and
velocity of these is matched by the subject to the density and velocity of spots on a VDU
screen which is observed with the other eye.
Grunwald et al used this method to examine the response of POAG, OHT and normal
eyes to increased intraocular pressure. They found that paramacular circulation in POAG
eyes reduced in response to raised intraocular pressure at a lower pressure than that in
OHT or normal eyes and attributed this difference to faulty autoregulation of retinal
blood flow in glaucoma^.
Sponsel et al found a correlation of better visual function with higher retinal leukocyte
velocity in a mixed group comprising 4 glaucoma patients and 8 ocular hypertensives 3
of whom had suspicious discs or fields. Eyes with higher leukocyte velocity had better
visual field (px0.05) and much better contrast sensitivity (pc0.001)H3.
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F. Animal Studies
Other more invasive methods of studying blood flow have been employed in animal
studies. For example radiolabeled or unlabelled microspheres may be injected into the
circulation and postmortem measurement of the density of trapped microspheres in the
tissues allows an estimation of blood flow. This technique has been used to study ocular
blood flow in cats' rabbits^, dogs' '4 an(j monkeys^.
Aim and Bill in 1973 used radiolabeled microspheres to investigate the effect of an
experimental increase in IOP on ocular blood flow in Macaque monkeys^. They found
that an increase of IOP to a mean of 41mmHg in one eye led to a 30% reduction in
choroidal and prelaminar blood flow in that eye when compared to the normotensive
fellow eye. No change was seen in retinal blood flow and the authors suggest that this
provides evidence for protective autoregulation in the retinal circulation. Sebag et al
measured blood flow in experimental optic atrophy in cats and found good agreement
between fluorescein angiography and the radiolabelled microsphere method '
Anderson et al performed surgical occlusion of the short posterior ciliary arteries in one
eye of squirrel monkeys. They found that this led to areas of geographic RPE atrophy
and outer retinal damage but caused only minimal damage to the optic nerve. They
proposed that the optic nerve is protected by an effective anastomotic supply from the
pial vessels and emphasised that the behaviour of optic nerve head blood flow cannot be
reliably predicted from choroidal or short posterior ciliary artery blood flow 67.
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Another method using tritiated iodoantipyrine was used by Quigley to investigate the
effect of long and short term increase in IOP in monkeys. He found no difference in
blood flow in the retina, optic nerve head or retrobulbar optic nerve unless IOP exceeded
75mmHg. Above this level a progressive decrease in optic nerve head blood flow was
seen 76. Weinstein et al used this method to investigate optic nerve head blood flow
with alteration of mean arterial blood pressure in cats. They found evidence to support
the presence of autoregulation of blood flow at the optic nerve head 116.
Sperber in 1985 used 2-deoxyglucose, a substance taken up by cells but which cannot be
metabolised, to determine ocular blood flow in monkeys subjected to increasing IOP. He
confirmed the presence of partial ischaemia of the optic nerve head and retina in eyes
with raised IOP 117. Bill and Sperber used the same method to provide evidence
supporting the existence of retinal vascular autoregulation in response to increased
demand in monkeys. They demonstrated an increase in inner retinal blood flow in eyes
exposed to flicker light 77.
Khoobehi described an alternative method using heat labile liposomes containing dye
which may be injected and then the dye released using laser lightl 18. Retinal blood flow
in individual vessels has been examined in primates using this method 119.
Funk et al used microendoscopy and spectroscopy to investigate the effect of intra¬
arterial injection of adrenaline on iris and ciliary body vessels in the rabbit. They found
prolonged vasoconstriction followed by vasodilation suggesting the possible presence of
sympathetic receptors in these uveal vessels 120.
63
Prior to this Stjernschantz demonstrated that intracranial stimulation of the oculomotor





In 1985 Phelps and Corbett published results of a study which found that 47% of a group
of 54 patients with normal tension glaucoma suffered from migraine 121. This compares
with an incidence in the general population of 20 to 30% 122 and raised the possibility
that an increased vasospastic tendency may have a role to play in causing visual field
loss in this type of glaucoma.
Drance et al in 1988 measured fingertip blood flow in groups ofNTG patients and
normal controls both with and without a history ofmigraine. They found that 65% of
NTG patients with no history of classic migraine had a vasospastic tendency seen as
reduced baseline blood flow and prolonged recovery time after immersion of the hand in
cold water. This incidence was very similar to that seen in control subjects with a history
ofmigraine (65%) but differed significantly from that in controls without migraine
(26%) 123.
There is a wealth of literature reporting similar findings in support of the theory that
vasospasm plays a role in the development of field loss in normal pressure
glaucoma!24. There is also evidence that vasospasm plays a role in the progression of
POAG. Broadway and Drance looked at the incidence of vasospasm in four previously
described clinical subtypes of primary open angle glaucoma (optic disc types 'focal
ischaemic', 'myopic glaucomatous', 'senile sclerotic and 'generalised cup
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enlargement'). They found a significantly higher incidence of peripheral vasospasm
(p=0.01) as measured with a laser Doppler flowmeter in the subgroup with 'focal
ischaemic' disc appearance associated with a higher reported incidence of migraine
(p=0.02) and cold extremities (p=0.00003), suggesting that vasospasm may play a role
in the development of field loss in some patients with primary open angle glaucoma125
Orgul et al looked at a mixed group of 11 NTG and 9 POAG selected on the basis of
continuing field loss despite controlled IOP. The implication was that the POAG group
had progressing damage due to compromised ocular circulation rather than pressure
related disease, they were therefore a highly selective subgroup of POAG patients. The
study found that the majority of subjects (13/20) demonstrated a vasospastic tendency as
shown by prolonged blood flow stand-still in nailfold capillaries after cold provocation.
Systemic blood pressure however was lower in the nonvasospastic group and the authors
suggest that both vasospasm and systemic hypotension may play a role independently to
produce progressive damage in glaucoma patients with field loss that does not respond
to pressure lowering treatment126
Systemic or ocular vasospasm has not been identified as a feature of ocular hypertension
although it has only been in recent years that a consensus has been reached on the
diagnostic criteria for this group. Many studies in the literature refer to 'glaucoma
suspects' and the lack of consistent diagnostic criteria make it difficult to draw
conclusions from the results. The ocular hypertension treatment study did not identify a
significant association between a history of migraine and the risk of progression to
glaucoma39.
66
Endothelin and Nitric Oxide
The vascular endothelium is an important functional unit in the regulation of vascular
smooth muscle tone. It has a diverse functions including control of permeability and the
activation and inactivation of hormones. It also affects the coagulation system, platelet
function and fibrinolysis and can release vasoactive substances which relax smooth
muscle e.g. nitric oxide, or produce vasoconstriction e.g. endothelin-1.
Endothelin and nitric oxide have been found to have an effect on ocular circulation and
also on intraocular pressure.
Endothelial dysfunction is implicated in the pathophysiology of vasospastic disorders
and both nitric oxide and endothelin-1 have been studied in the context of vascular
insufficiency in glaucoma. Endothelin-1 converting enzyme (ECE-1) produces
endothelin-1 from a biologically inactive substrate 'big endothelin' and has been
identified immuno-histochemically in the endothelium and vascular smooth muscle of
the blood vessels of the retina, optic nerve and choroid 127 An endothelin-1 receptor
agonist sarafotoxin has been found to lower intraocular pressure in rabbits by regulating
aqueous humour dynamics128. Sugiyama et al found elevated plasma endothelin
concentration in normal tension glaucoma129. On the basis of these and other studies
selective antagonists of endothelin-1 have been proposed as possible therapeutic agents
in glaucoma!30.
Calcium channel blockers selectively inhibit endothelin-1 induced contraction of porcine
ciliary artery in vitro131 ancJ calcium channel blockers such as nifedepine may have a
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therapeutic role in glaucoma patients with vasospastic tendency. Gaspar et al found that
nifedepine improved visual field in NTQl325 and Tomita et al found that it produced a
significant reduction in orbital vascular resistance and an increase in optic nerve head
blood flow 133 . Magnesium is a physiological calcium channel blocker and it has been
found to improve peripheral circulation and visual field in glaucoma patients with a
vasospastic tendency134
Nitric oxide is involved in the control of basal blood flow in the choroid, optic nerve and
retina. In addition it performs several other roles; it mediates vasodilation in ocular
vessels in response to numerous agonists including acetylcholine, substance P and
insulin. It is involved in hypercapnia induced vasodilation in the choroid and is a
modulator of autoregulation in this vascular bed 135. Reduced levels of nitric oxide have
been found in the aqueous humour of POAG patients undergoing cataract surgery
compared to patients with cataract alone and, as with endothelin, the nitric oxide




Blood Rheology and Glaucoma
Blood flow through a tissue is dependant on the perfusion pressure and the vascular
resistance in that tissue. Factors influencing the viscosity of the blood will have an effect
on perfusion by altering resistance to flow. For this reason investigators have looked for
haematological changes in glaucoma in an attempt to better understand the aetiology of
the disease.
Coagulation
Drance and associates in 1973 137 identified a 'greater tendency to thrombosis' in 30 of
45 patients with normal pressure glaucoma (NPG) due to increased platelet adhesiveness
and abnormal euglobulin lysis time. This introduced the idea that a hypercoagulable
state may be a contributing factor in the development of glaucoma. Subsequent studies
produced mixed results. Joist et al found no difference in NTG subjects compared to
normals when they measured blood coagulability, platelet function, and fibrinolysis!^.
Klaver et al also found no significant differences in fibrinogen comparing groups of
NTG, POAG and normals 139
Previous published findings from this department!^ showed a significant increase in
prothrombin fragments 1 and 2 and increased levels of D-dimer in untreated POAG and
NTG compared to normals suggesting activation of the clotting cascade in those groups.
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The POAG group had a higher incidence of systemic vascular disease and higher blood
pressure than the other two groups which may have contributed to the findings.
Plasma viscosity
Klaver et al identified increased whole blood and plasma viscosity in NTG compared to
normals. Whole blood viscosity and packed cell volume were also found to be
significantly increased in POAG subjects but this may have been due to higher levels of
smoking in this group139
Trope et al measured blood viscosity, haematocrit and plasma fibrinogen in 27 POAG
subjects and 18 controls matched for sex, mean arterial blood pressure and smoking
habits. They found significantly increased blood viscosity in POAG but no difference in
the other two parameters and they suggest raised plasma viscosity, increased levels of
plasma proteins or changes in erythrocyte deformability as possible causes for this
finding 141.
This theory was supported by the findings ofWolf and associates who recorded
increased plasma viscosity in POAG associated with increased retinal arteriovenous
passage time and reduced mean dye velocity compared to normals using fluorescein
angiography. In addition to thisWolf also found no significant difference between
normal and POAG in haematocrit or erythrocyte aggregation 110.
In contrast Carter et al in a prospective study of lipid profiles and blood rheology
including coagulation and blood viscosity, found no significant differences between
groups of 46 NTG, 69 POAG and 47 normal subjects. There was however a
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nonsignificant trend towards increased blood viscosity in glaucoma in this study and the
authors state that they used a different method to measure viscosity to that used in
previous studies 142.
A problem encountered with all the above studies is the difficulty of controlling for
other factors which influence viscosity such as age, cardiovascular disease and smoking
in the elderly glaucoma population. In addition the possible confounding effect of
concurrent treatment to lower intraocular pressure is seldom addressed.
Erythrocyte abnormalities
In 1993 Mary et al reported an investigation into erythrocyte deformability and
aggregability, plasma fibrinogen and haematocrit in 21 POAG and 18 age matched
control subjects. They found significantly reduced erythrocyte deformability in POAG
but no difference in any of the other parameters. They propose that this may explain the
previous finding of increased blood viscosity in glaucoma143. Reduced red cell
deformability may be induced by platelet activation and oxygen free radical generation
both of which have been implicated in glaucoma.
The following year Hamard et al published their findings of increased erythrocyte
aggregation in POAG 144.
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Platelets
Hoyng et al found a higher incidence of in vitro platelet aggregation in a mixed group of
NTG and POAG patients with progressive field loss compared to glaucoma subjects
with stable fields or ocular hypertensives. They suggested that aggregations of platelets
at the optic nerve head may cause microinfarctions leading to splinter haemorrhages and
field loss 145
Hayreh et al published results of a study looking at the effect of serotonin, which is
released when platelets aggregate, on the retinal and posterior ciliary circulation in
monkeys fed on an 'atherogenic' diet high in cholesterol. They found that in the
presence of atherosclerotic lesions serotonin can cause transient, complete or partial
occlusion in the central retinal artery and posterior ciliary arteries. This serotonin




Other Risk Factors in
Glaucoma and Ocular Hypertension
In addition to the topics already covered in this review there have been numerous studies
searching for other possible risk factors associated with field loss in glaucoma and
ocular hypertension.
Systemic Haemodynamic Factors
The relationship between systemic blood pressure and glaucoma is not straightforward
and there are conflicting reports in the literature regarding the influence of blood
pressure on the risk of visual field deterioration.
Arterial Hypertension
Many studies have reported an association between high systemic blood pressure and
raised intraocular pressure147,148
The Framingham Eye Study25 found that subjects with IOP above 21mmHg in at least
one eye had an increased prevalence of systemic hypertension and diabetes, and in
multiple regression analysis systolic blood pressure was the variable most related to IOP.
73
However, no association was found between IOP and cardiovascular disease (defined as
the presence of coronary heart disease, atherothrombotic brain infarction, intermittent
claudication, or congestive heart failure). In addition they found that while subjects
without visual field defects demonstrated an association between IOP and blood pressure
(higher blood pressure being associated with higher intraocular pressure) thoscwith field
defects did not. This resulted in a lower ratio of blood pressure to intraocular pressure in
the group with field loss giving support to the vascular hypothesis of optic nerve
damage.
Wilson et al also found an association between high IOP and systemic hypertension in a
case control study to investigate risk factors in glaucoma and OHT. They found that
black race and untreated systolic hypertension were the most important risk factors for
having glaucoma in their group of 83 POAG, 121 OHT and 237 controls. They also
found 'suggestive' associations between glaucoma and cigarette smoking, family history
of glaucoma, definite or borderline diabetes and myopia. Similar but weaker associations
were noted for the OHT groupie.
The relationship between systemic hypertension and IOP was explored byWilliams et al
in 1984. They found that normal subjects with untreated systemic hypertension had a
significantly elevated mean level and variance of IOP in the morning and a greater
increase in IOP on lying down in comparison to normotensive individuals 149
Despite the acknowledged association of high systemic blood pressure with glaucoma it
is not a good predictor of future field loss in ocular hypertensives^1,150. The Ocular
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Hypertension Treatment Study (OHTTS) failed to find any association between high or
low systemic blood pressure and the risk of developing POAG^.
Arterial Hypotension
Heyreh et al measured 24-hour ambulatory blood pressure in a mixed group of 166
patients with 'ocular ischaemic disorders' including NTG (n=67) and POAG (n=21).
They found a significant reduction in systolic and diastolic blood pressure at night.
Patients with treated arterial hypertension showed a significant association between
progressive field loss and nocturnal hypotension. There was no correlation found
between IOP and field loss in this study. The authors postulate that ocular ischaemia
secondary to reduced perfusion pressure causes field loss and that subjects with a history
of systemic hypertension are particularly susceptible to this due to hypertensive changes
in the ocular blood vessels 151.
These findings were confirmed by Kaiser and associates when they found that POAG
patients with progressing field loss despite controlled IOP had significantly lower
systolic blood pressure both day and night than normal controls 152.
Meyer et al studied a group of 20 normal tension glaucoma patients. They found that
NTG patients had slightly lower blood pressure than controls overall (non significant)
but that they had significantly greater nocturnal blood pressure dips (p<0.001)153
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Systemic vascular disease
The OHTTS identified heart disease as a predictive factor for the development of field
loss in ocular hypertension on univariate analysis^.
The Framingham eye study found no association between high IOP and history of
cardiovascular disease but did find an association with important risk factors for
vascular disease; systemic hypertension and diabetes^.
Walker et al found a higher incidence of systemic vascular disease in POAG (n=50) and
OHT (n=45) than in normals but there was also a significantly higher number of
smokers in these groups154.
Optic Disc Haemorrhages
For many years there has been a known association between splinter haemorrhages at
the neuroretinal rim and glaucoma damage. In a long term study of 1270 patients optic
disc haemorrhages were seen in 20% of POAG patients and were found to be a precursor
of glaucomatous disc changes and associated visual field defects. This finding was seen
independent of IOP and the authors suggest that the finding supports the vascular theory
of damage in POAG 155
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Non Vascular Risk Factors
Age
The effects of age on IOP are discussed in detail in chapter 1.4.
Many studies have identified an increasing incidence of POAG with age 1-56. Quigley
described the prevalence of POAG in a European-derived population as following an
exponential curve sharply increasing above the age of 75. Prevalence among African and
Asian derived people follows a linear function increasing with age with a steeper
gradient on the line for Africans^.
Hart et al in a retrospective study of 92 OHT patients 33 of whom developed field loss
over 5 years found that the strongest predictors of future field loss were age, mean IOP,
vertical cup to disc ratio, and a positive family history of glaucoma*^.
The OHTTS also found that age was an important risk factor for the development of
field loss both on univariate and multivariate analysis^.
Optic disc and nerve fibre layer appearance
Unsurprisingly optic cup enlargement and nerve fibre layer defects have been found to
be associated with increased risk of future field loss. Studies have shown that a
significant proportion of nerve fibres are lost in glaucoma before detectable field loss
appears Patients with observed disc or nerve fibre layer changes may in fact have
very early disease.
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Quigley et al followed a group of 647 ocular hypertensives (40% of whom were
receiving treatment) for 12 years. Sixty eight subjects developed field loss during
followup. Moderate or severe nerve fibre layer atrophy at baseline was associated with a
7 to 8 times greater risk of field loss. Other attributes significantly associated with field
loss were larger cup to disc ratio, smaller rim to disc area ratio, greater optic cup
asymmetry, presence of optic disc crescent, older age and higher IOP^l.
The association between smaller area of neuroretinal rim, larger area of peripapillary
atrophy and risk of progression of glaucomatous field loss was confirmed by Jonas et al
in a prospective observational study of 257 glaucoma patients 158.
Budde and Jonas also investigated whether the presence of a cilioretinal artery
influenced the pattern of neuroretinal rim loss and parapapillary atrophy in glaucoma.
They found that the presence and position of cilioretinal arteries did not appear to have
an effect on the pattern of progressive disc changes 159
Myopia
The Blue Mountains Eye Study 24 found an increased incidence of glaucoma in myopic
eyes. Glaucoma was present in 4.2% of eyes with -1 to -3 dioptres ofmyopia, 4.4% of
eyes with over 3 dioptres myopia and only 1.5% of non myopic eyes. The odds ratio
after adjusting for known glaucoma risk factors was 2.3 for low myopia and 3.3 for
moderate to high myopia. There was a borderline association between myopia and
ocular hypertension (odds ratio 1.8 for low myopia and 0.9 for high myopia).
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The association between myopia and open angle glaucoma has been confirmed by other
authors 148 although the presence of myopia in ocular hypertensives was not found to
hold any predictive value for progression to field loss in the OHTTS.
Diabetes mellitus
Dielemans et al reported the findings of the Rotterdam Study which included 4178
individuals over the age of 55yrs. They found that newly diagnosed diabetes and high
levels of blood glucose were associated with ocular hypertension and glaucoma^. This
finding has been confirmed by others^,148.
Conversely diabetes was found to have a protective effect against developing POAG in
the OHTTS. This may be explained by the exclusion of patients with diabetic
retinopathy from the study leading to an unrepresentative, healthier group of diabetics^.
The conflicting results from studies looking at the relationship between POAG and
diabetes may be explained by the coexistence of a number of confounding factors in
diabetics. They may have large or small vessel disease, autonomic neuropathy, systemic
hypertension, diabetic retinopathy and optic neuropathy, all of which may have an effect
on visual function and ocular blood flow. In addition to this diabetic subjects with severe
diabetic retinopathy are often excluded from ophthalmic studies. Finally diabetics as a
group are exposed to routine eye examination including dilated fundoscopy more
frequently than the general population and this may make it more likely for a diabetic
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with POAG to be identified while a higher proportion of non-diabetic glaucoma patients
remain undiagnosed.
Race
African derived people tend to develop POAG at a younger age and the disease runs a
more aggressive course than in European or Asian derived populations^.
The Baltimore Eye Survey found that age adjusted prevalence rates for glaucoma in
blacks were 4 to 5 times higher than in whites^.
Wilson et al also found that black race was one of the strongest predictors of field loss in
their study ofOHT, POAG and normals 1^®.
Genetics/Family history
A family history of glaucoma or ocular hypertension has been identified in many studies
as a risk factor for developing the disease1^0.
In 1997 Stone and associates identified a gene (TIGR) associated with juvenile open
angle glaucoma and screening of adults with POAG found that 4% of this group also
carried a mutation in the coding region for this gene160 Since then many more
mutations in the TIGR gene sequence (now replaced with the term myocilin, abbreviated
to MYOC) have been identified in patients with glaucoma. Other genes related to
specific conditions associated with glaucoma such as PITX2 in Rieger syndrome161,
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F0XC1 in Axenfeld-Rieger anomaly 162? and CYP1B1 in autosomal recessive
congenital glaucoma163 have also been identified.
The Glaucoma Inheritance Study in Tasmania identified eight pedigrees with the most
common MYOC gene mutation. However within those eight families only half of those
with POAG or OHT carried the mutation and not all of those with the mutation had
evidence of POAG or ocular hypertension164. This highlights the fact that although
myocilin mutations are the most commonly found genetic abnormality implicated in
glaucoma they account for a very small proportion of glaucoma cases overall.
Studies have also looked at genetically based mechanisms through which vascular
endothelial cells undergo changes in structure and function in response to laminar shear
stress. It has been found that positive and negative transcriptional regulatory elements
combined with shear-induced transcription factors can provide a mechanism for
coordinated patterns of response of otherwise unrelated genes in the endothelial cell165
In other words the expression of genes in the vascular endothelium is regulated in part
by haemodynamic factors.
Gender
The Framingham eye study found that men were more than twice as likely as women to
have POAG166 an earlier Swedish study found that women were at higher risk than
men6, but the majority of studies have found no consistent gender difference in the
incidence of POAG ^,7.
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Alcohol and Smoking
A weak association between smoking and POAG has been noted in the literaturel^.
However colour Doppler studies of orbital blood flow in smokers have identified
increased blood flow velocities particularly in the ophthalmic artery in the absence of
increased resistance. This is thought to be due to an increased sensitivity to endogenous
vasodilators in healthy smokers167. A similar effect has been recorded in non smokers
given a low dose of nicotine via chewing gum!68 The relationship between smoking
and glaucoma may be due to their common association with systemic vascular disease in
later life.
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Summary of Section I
Section I introduces the topics covered by this investigation and reviews the literature on
blood flow in primary open angle glaucoma and ocular hypertension.
Primary open angle glaucoma and ocular hypertension are defined. Epidemiological
studies related to the conditions are reviewed. A review of the literature on normal IOP
variation and control is followed by a review of investigations into the effects of
lowering IOP in the long or short term in OHT and POAG. Normal ocular circulation is
described and the results of investigations into physiological controls on blood flow to
the eye are related. The reported effects of alterations in IOP on the ocular circulation
are reviewed. In chapter 1.6 different methods used to investigate blood flow are
described and studies comparing blood flow in OHT and POAG are reviewed.
Peripheral vasoreactivity in glaucoma is discussed in chapter 1.7 and studies of
haematological changes in glaucoma are reviewed in chapter 1.8. The final chapter of
Section I lists other vascular and non-vascular risk factors which have been identified as
playing a possible role in the development of glaucoma.
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1. To determine if differences in ocular blood flow exist between POAG and OHT which
can be attributed to the presence of disease rather than intraocular pressure or treatment.
2. To compare groups of prospectively recruited, untreated POAG and OHT patients
matched for intraocular pressure.
3. To investigate choroidal and retinal blood flow in POAG and OHT.
4. To investigate clotting parameters including markers of platelet activation in POAG and
OHT.
5. To investigate peripheral vasoreactivity in POAG and OHT.
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2.1
Patient Recruitment and Study Protocol
Ethical approval
Ethical approval was granted for the study by Lothian Research Ethics Committee and
informed consent was obtained from all subjects. (See copy of consent form and
information sheet, appendix B)
Subject Selection
Patients were recruited prospectively over a fourteen month period from glaucoma
clinics at the Princess Alexandra Eye Pavilion Edinburgh. This institution is the sole
referral centre for ophthalmology for Edinburgh City, East Lothian and Midlothian
districts. The estimated population served by the hospital was 617,030 in the first year of
this study, of whom 94,546 were aged 65 and above. All new patients seen in our clinic
who met study criteria and were able to travel to and from the hospital without difficulty





Glaucoma patients had an intraocular pressure on presentation greater than 21 mmHg,
open drainage angles on gonioscopy, optic disc cupping and characteristic visual field
defects on testing with the Humphrey visual field analyser (24-2 threshold program).
Clinical diagnosis was confirmed in all cases by an experienced glaucoma specialist
(COB).
Ocular Hypertensives
Ocular hypertensive patients had intraocular pressure of over 21mmHg and full visual
fields as assessed with the Humphrey visual field analyser 24-2 threshold program.
Optic disc appearance in ocular hypertensive subjects was noted but was not part of the
inclusion criteria. A decision was made not to include optic disc appearance in the
criteria for diagnosis of POAG and OHT. This was because of the difficulty in obtaining
a truly objective assessment of glaucomatous damage based on the appearance of the
disc at a single examination. It was expected that the OHT group would contain some
preglaucoma subjects both in terms of both optic disc changes and blood flow. No
attempt was made to identify these patients at the recruitment stage. The ocular
hypertensive group was subdivided into 'high risk ocular hypertensive' (HROHT) and
'low risk ocular hypertensive' (LROHT) on the basis of intraocular pressure. A
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maximum intraocular pressure less than or equal to 25mmHg was considered 'low risk',
a maximum pressure of 26mmHg or above was 'high risk'.
All subjects had central visual acuity of 6/9 or better in the study eye. All measurements
were made on both eyes, the eye with the worse visual field was taken as the study eye
in glaucoma subjects. For normal subjects and ocular hypertensives the eye with the
higher IOP was selected or, if there was no difference between the eyes one eye was
chosen at randomly tossing a coin.
Normal control subjects
Normal subjects were friends or spouses of patients. They had normal intraocular
pressure and no signs of ocular disease on examination. They had no previous history of
eye disease or ophthalmic surgery. As in the patient groups, normal subjects had a visual
acuity of 6/9 or better in the study eye and full visual fields on testing with Humphrey
visual field analyser (Armaly programme).
Fifty-one ocular hypertensives, 24 glaucoma patients and 23 normal subjects were
recruited to the study over the course of fourteen months.
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Exclusions
Exclusion criteria were as follows:
A history of use of topical antiglaucoma medication or topical steroid to the eye.
A history of eye disease or previous eye surgery.
The concurrent use of systemic vasoactive medications e.g. systemic nitrates,
betablockers or calcium channel blockers.
An inability to sit at the slit lamp or difficulty attending the hospital due to physical
disability.




Arrangements were made for the subjects to attend the hospital for one day during which
the following protocol was observed.
1. Consent and questionnaire
2. Full ocular examination including Goldmann tonometry and gonioscopy.
3. Venepuncture
4. Pulsatile ocular blood flow measurement in sitting, standing and supine positions.
5. Laser Doppler finger capillary blood flow with temperature stress test
6. Heidelberg laser Doppler retinal blood flow measurement
7. Visual field testing; Humphrey 24-2 programme for POAG and OHT subjects,
Armaly visual fields for normal subjects.
8. Axial length (Ocuscan biometry machine, Alcon Labs UK Ltd)
9. Intraocular pressure measurement at 9am, 1 lam and 1pm.




Patients and controls were asked to attend the hospital at 8.30 am. On arrival they were
given the patient information form to read and informed consent was obtained. The
questionnaire covering past medical and ocular history (see appendix B) was completed
before commencing the investigations.
Ocular examination
Best corrected Snellen visual acuity was recorded. Anterior segments of both eyes were
examined with the patient seated at the slitlamp. Intraocular pressure was measured with
a Goldmann tonometer and gonioscopy was performed with a contact lens following
tonometry.
Venepuncture
Blood was taken for the following; full blood count, beta-thromboglobulin, fibrinogen,
prothrombin fragments F 1 and 2 (PTF1&2) and D-dimer. All blood tubes were kept on
ice, venepuncture was performed with as little trauma as possible using a 19 gauge
needle, one 5ml syringe and two 10ml syringes. Blood was drawn without compression
on the vein and the first 5ml drawn were used for the full blood count. Particular care
was taken in the handling of the sample for beta thromboglobulin. All samples were
transported immediately on ice to the haematology lab where the full blood count was
recorded and the remainder of the samples were spun down and frozen (-70 °C).
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Pulsatile ocular blood flow
Following venepuncture and after a 15 minute break, subjects were seated at the slit
lamp for 5 minutes. Blood pressure and pulse were measured with an automatic cuff
(Criticon Dynamap, Tampa, Fla). Pulsatile ocular blood flow, pulse amplitude and pulse
volume were measured with the pneumotonometer mounted on a slit lamp. We used the
ocular blood flow system developed by OBF labs UK (System 3000, Version 14.4,
Revision 4). The subject was then asked to stand for 5 minutes. The blood pressure,
pulse and POBF measurements were repeated with the pneumotonometer hand-held by
the examiner. Finally the subject was placed in a supine position for 5 minutes and the
measurements were repeated. The pneumotonometer was again hand-held for this
measurement.
Laser Doppler finger capillary blood flow
For measuring changes in fingertip capillary blood flow we used the Periflux laser
Doppler flow meter for microvascular perfusion produced by Perimed KB (PO Box
5607, Stockholm, Sweden)
After POBF measurement subjects were seated for a further 5 minutes. Ambient room
temperature was noted. The probe for the laser doppler flow meter was applied to the
middle finger of the left hand and a baseline blood flow reading was taken. The left hand
was then immersed in a water bath at 40 °C for 2 minutes, on removal the hand was
wrapped in a towel to limit heat loss and peak blood flow was recorded from the finger
tip. Blood flow was observed returning to baseline level and then the left hand was
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placed in a mixture of ice and water at—4°C for 10 seconds. The minimum flow was
noted and the time taken for the blood flow to return to normal was recorded.
Heidelberg laser Doppler retinal blood flow measurement
The Heidelberg retinal flowmeter was used to take flow images of the study eye. Images
were taken in the late morning in a windowless room with consistent background
lighting. A 2.5°x 10° frame was used centred on the optic disc and focused on the retinal
vessels. Pupils were undilated and ambient lighting was standardised. The images taken
were stored and reviewed at a later date as detailed in chapter 2.2.
Intraocular pressure measurement
Intraocular pressure was measured with a Goldman tonometer with the subject seated at
the slit lamp at 2 hourly intervals during the course of the visit (phasing). In addition to
this, maximum and minimum IOP readings recorded by the OBF pneumotonometer in
sitting and supine positions were noted.
Review visit
Subjects were started on antiglaucoma medication after the study visit if required, and
all were reviewed in the outpatient clinic in the usual way. Fourteen glaucoma patients
(6 female 8 male) and eleven high risk ocular hypertensives (5 female 6 male) were
recalled for repeat study measurements after commencing anti glaucoma medication.
113
The average time interval between investigations was 15.8 months. The treatment for
each patient was selected on an individual basis and was therefore not standardised.
Twenty three patients were on betaxolol 0.5% bd (Alcon), seven required a second
topical drug in addition to betaxolol and of these four were on dorzolamide 2% tds
(MSD), one was on latanoprost 0.005% once daily (Pharmacia), one was on brimonidine
tartrate 0.2% bd (Allergan) and one on pilocarpine 1% qds. Three were unable to
tolerate betablockers and were therefore started on dorzolamide 2% tid (MSD). See
tables 3 and 4.
Table 3: Numbers of patients reviewed
Male Female total
Treated POAG 6 8 14
Untreated POAG 0 0 0
Treated HROHT 5 6 11
Untreated HROHT 1 1 2
Treated LROHT 0 1 1
Untreated LROHT 3 4 7
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Table 4: Details of treatment and follow-up







3 hroht B 24 no
5 LROHT B 26 no
8 POAG B 23 no
13 POAG B L 22 no
14 hroht B 25 no
19 POAG B 24 no
20 POAG B 12 no
21 POAG dz 12 no
24 hroht B 21 no
25 hroht B 23 no
27 hroht B 23 no
30 hroht B dz 12 no
32 POAG B a 14 no
33 hroht B 17 no
37 POAG B dz 17 no
42 hroht B 16 bendrofl.
46 POAG B 5 no
47 hroht dz 15 aspirin
50 hroht B 17 no
55 POAG B P 15 no
56 POAG B dz 4 no
64 POAG B dz 7 no
68 POAG B 7 no
70 hroht B 11 no
71 POAG dz 11 no
74 POAG B 10 no
Key: B = betaxolol
dz = dorzolomide





In general when data was normally distributed comparisons across four groups were
made using a two way ANOVA with Bonferroni correction and comparisons between
two groups were made using the unpaired Student t test The chi squared test was used
for categorical data. Data was checked for skewdness and if not normally distributed
was examined using non-parametric tests. The MannWhitney U test was used for paired
comparisons and the Kruskall Wallis ANOVA was used for comparisons across 4
groups. Statistical significance was set at p ^ 0.05. Correction was made for age when
necessary using partial correlation when continuous data was normally distributed or
multiway logistic regression if not. All statistical calculations were made using SPSS




Methods and Statistical Analysis
A. Pulsatile Ocular Blood Flow
The POBF machine used in this investigation was developed by OBF Labs UK Ltd. It
consists of a pneumatic probe linked to an internal compressor which supplies filtered
air to the tip and a computer which displays the blood flow parameters (figure 8). The
face of the pneumatic probe consists of a thin membrane. It is kept in contact with the
cornea by a light flow of air within the tip which gently holds the sensor against the eye
with a constant force. As the pressure in the eye changes the pressure required to
applanate the cornea varies. These subtle changes in pressure are continuously
monitored by the POBF machine. During the test the IOP is monitored 200 times per
second. The computer filters this signal using real time analysis and constructs an image
of each pulse. The 5 pulse wave forms that are closest to each other in IOP variation
with time are automatically averaged by the computer software and used in the
calculation of the ocular pulse characteristics and the POBF. A digital display provides
information about the IOP (mmHg), pulse amplitude (mmHg), pulse volume (pi),
systolic and diastolic time (seconds), pulse rate (beats per minute), and POBF (pi /min).
The information displayed by the computer is stored on a floppy disc and may be printed
out in a standard format (figure 9).
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Figure 8: OBF machine and pneumatic tip
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P.A.E.P.
Chalmers Street Edinburgh Ep3 0666 822269
OBF Test recorded using OBF Labs (UK) Ltd Tonograph, Copyright 1992.
The test was carried out with the patient at a slit lamp








Right Eye Pulse: Average
Minimum Intraocular Pressure [mmHg] 32.0 32.4 31.8 33.8 32.0 32.4
Maximum Intraocular Pressure [mmHg] 34.0 34.5 33.6 35.9 34.1 34.4
Average Intraocular Pressure [mmHg] 33.0 33.4 32.7 34.9 33.0 33.4
Pulse Amplitude [mmHg] 2.0 2.1 1.8 2.1 2.1 TTIJ~"
Pulse volume [pi] 2.3 2.4 2.1 2.3 2.4 2.3
Systolic Time [sec] 0.28 0.30 0.31 0.29 0.32 0.30
Diastolic Time [sec] 0.39 0.34 0.32 0.37 0.35 0.35
Pulse Rate [/min] 89 93 95 90 89
Pulsatile Ocular Blood flow [pl/min] 365 453 470 491 527 r46p
OBF % Standard Deviation ~~T2T
MNI : 813 PEQ : 2.8 IDR : 46
Left Eye Pulse: 1 2 3 4 5 Average
[mmHg] 31.7 32.0 31.8 32.0 32.1 31.9
[mmHg] 33.7 33.8 34.0 34.2 34.2 34.0
[mmHg] 32.7 32.9 32.9 33.1 33.2 33.0
[mmHg] 2.0 1.9 2.2 2.3 2.1 2.1
[Ul] 2.2 2.1 2.5 2.6 2.4 2.4
[sec] 0.24 0.26 0.30 0.25 0.30 0.27
[sec] 0.41 0.37 0.40 0.38 0.33 0.37
[/min] 92 95 85 95 95 93
[pl/min] 379 413 450 505 526 *8*









Pulsatile Ocular Blood flow
OBF % Standard Deviation
MNI : 910 PEQ
Comments :-
The right eye recordings were repeated tests.
The left and right eye IOP seems to be high.
OBF Labs Page 1 of 2
Figure 9: Data sheet produced bv OBF machine
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POBF is automatically calculated by the machine from an analysis of the IOP pulse
waveform, pulse rate and the ocular pulse amplitude. The calculations and underlying
assumptions used to derive POBF are described in a paper by D. Silver^. In summary,
for the purpose of POBF calculation the eye is represented as a chamber with elastic
walls with a pulsatile incoming flow of incompressible fluid and a steady outgoing flow.
It is assumed that outflow from the eye remains constant, that there is no reflux and that
the pressure volume relationship (ocular rigidity) derived from Langham's living eye
experiments in the 1960s can be applied to all eyes^.
Repeatability studies using this machine were carried out by Z. Butt prior to the
investigation reported here^ using intraclass correlations of five repeated POBF
measurements on 20 patients. Intraclass correlation is derived from the equation;
Patient's variance
Total variance
It is therefore an assessment of the proportion of total variance that can be attributed to
the patients. For this investigation the result was not significant (p=0.15) signifying good
repeatability.
Other studies have looked at the reliability ofmeasurements with this machine. Yang et
al found an acceptable reliability coefficient of 0.92 for POBF values from 290 pl/min to
2196pl/min 4
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All measurements in this study were performed by one, experienced operator (JK),
following the technique described by Butt.
Axial length was measured in each subject using a biometry machine.
Statistical analysis of group comparisons was performed using ANOVA with the
Bonferroni correction for pairwise comparisons when the overall f test was significant,
i.e. if a significant difference was found to exist across the 4 groups the Bonferroni
correction identified between which groups the significance lay. Results were adjusted
for age. Paired comparisons (the effect of treatment and the effect of posture) were made
using the Student t test. The chi-squared test was used for categorical data. Partial
correlations were performed for males and female separately correcting for age.
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Figure 10: Heidelberg Retinal Flowmeter
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B. Retinal Blood Flow: Scanning Laser Doppler Flowmetry
Laser Doppler flowmetry developed as a non-invasive technique for measuring blood
flow in the retina and optic nerve head. In this study we used the Heidelberg Retinal
Flowmeter (HRF, Heidelberg Engineering Germany), a machine which combines a
confocal laser scanning system with laser Doppler flowmetry described in 1995 by
Michelson and Schmauss 5.
The measurement of blood flow by laser is based on the optical Doppler effect. Laser
light reflected by a moving particle is shifted in frequency by an amount Af according to
the equation:
Af=(l/2jt)(ksc—kj)v
Where is the wave vector of the scattered light, kj is the wave vector of the incident
light and v represents the velocity vector of the incident light. Using an infrared laser
(wavelength 780nm) the HRF scans the retina two-dimensionally. Light reflected or
scattered by moving red blood cells is frequency shifted due to the optical Doppler
effect. It interferes with light reflected by stationary objects resulting in a characteristic
temporal variation of the reflected light intensity. The HRF measures this temporal
variation at each point in a two dimensional field by multiple scanning. The frequency
shift of the reflected light is computed from the acquired data and used to quantify the
local amount and velocity ofmoving red blood cells. The size of the measurement field
on the retina is from 10 by 2.5 degrees up to 20 by 5 degrees. Within this field the
temporal variation of the reflected or scattered light is measured at 256x64 points. Total
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data acquisition time is 2 seconds. Perfusion maps are produced from the acquired data
in which the brightness of each point or pixel is coded by the value of the Doppler shift
of laser light reflected from that point. The observer acquires numerical information
about "flow" (the distance travelled by all moving red blood cells inside the sample
volume per unit time), "volume" (the number of moving red blood cells), and "velocity"
(mean red blood cell speed) by placing a "region of interest" square on the image to
select a sample volume which is 2,560 x 640 x 400 pm in size.
We used a 2.5 x 10 degree frame centred on the optic disc and focused on the retinal
vessels. Images were taken in the late morning. Pupils were undilated and ambient
lighting was standardised. For the purpose of analysis we divided the flowmeter image
into five areas; nasal retina, nasal neuroretinal rim, optic cup, temporal neuroretinal rim
and temporal retina (Figure 8).
One problem with the use of the SLDF is the potential bias produced by subjective
positioning of the sample square on the image. It is possible to obtain very different
results within a given anatomical area simply by moving the sample square a small
distance, this is the case even when visible blood vessels are avoided and occurs
presumably because the capillary network is not uniform. We attempted to reduce
potential bias by increasing the number of samples taken in each area and recording the
maximum and minimum sets of results obtained (volume, velocity and flow).
Measurements were made using a 10x10 pixel square and up to 10 samples were taken
in each area. Areas of peripapillary atrophy and visible blood vessels were avoided when
placing the square.
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Figure 11: Schematic representation of the optic nerve head and peripapillary retina.
The area of the retinal flowmeter image is within the shaded box. Numbers indicate the
different areas of measurement as discussed in the text.
1= nasal retina, 2= nasal neuroretinal rim, 3= optic cup, 4= temporal neuroretinal rim,
5= temporal retina.
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Reliability coefficients for 'flow', 'volume' and 'velocity' were found to be 0.84, 0.85
and 0.84 respectively in the paper by Michelson which looked at 5 consecutive
measurements in the same retinal area in one eye of 12 individuals. The validity of the
method was investigated in the same paper and a significant linear relationship was
found between SLDF flow and the ocular perfusion pressure when the latter was varied
with a suction cup. It was also found that there was a linear relationship between the
SLDF measurement and a pre-existing laser Doppler flowmeter suggesting that the two
methods measure the same thing**.
For statistical analysis of the SLDF results the Kruskal-Wallis ANOVA was used and
comparison was made maximum with maximum and minimum with minimum results
between the groups in each of the five areas. Comparison between OHT and POAG was
performed using the Mann Whitney U test.
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C: Haematological investigations
Blood samples were taken from each patient according to the protocol described in
chapter 2.1. Blood was transferred to one EDTA tube (3.5ml for full blood count), one
BTG tube (5ml) and two sodium citrate tubes (3ml each, for fibrinogen, prothrombin
fragments 1 and 2, and D-dimer). The following methods were used for analysis of the
samples.
B-thromboalobulin
The BTG sample was spun at 2000rpm for 30 minutes and stored at -70°C. (J-
thromboglobulin levels were measured using a radioimmunoassay kit (Kodak Clinical
Diagnostics Ltd, Amersham UK). Betathromboglobulin is a platelet specific protein
released into the circulation when the blood platelets are activated. The protein was
isolated, characterised and named in 1975 by Moore, Pepper and Cash '. It is the most
abundant platelet specific protein and is located in the a-granules of the platelets.
Elevated levels have been found in patients with subacute deep vein thrombosis, pre
eclampsia and in some infections. Normal mean values supplied by the manufacturers of
the assay kit are within the range 24-28ng/ml. They report occasional high readings in
normal individuals due to problems with the technical processing of the sample which
must be taken atraumatically, cooled quickly and treated gently to prevent platelet
degranulation prior to assay.
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Full Blood Count
Full blood count and differential were measured in the standard way using a Sysmex
8000 FBC counter.
Clotting Factors
Blood from the sodium citrate tubes was centrifuged at 4000rpm for 10 minutes.
Fibrinogen was measured using the Clauss method.
Prothrombin fragment F1 and 2 was assayed by ELISA (Enzygnost, Dade Behring
Marburg GmBH, Germany).
The conversion of prothrombin to thrombin is a key event within the coagulation
cascade. Quantification of prothrombin fragment F 1 and 2 gives information about the
amount of thrombin formed. Elevated levels are found in patients with thrombosis,
pulmonary embolism, DIC, polytrauma and septicaemia and in the plasma of patients
with hereditary protein C or protein S deficiency. Levels are reduced in patients taking
oral anticoagulants.
D-dimer was also assayed using ELISA (Coa test, Chromagenix AB, Sweden).
Blood samples were collected and plasma prepared for these investigations with
appropriate precautions as recommended by the manufacturers of the assay kits.
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Statistical analysis of blood results
Comparison of results across the four diagnostic groups was made using Kruskall Wallis
ANOVA because some of the data was not normally distributed. Demographic variables
were normally distributed and were compared using one-way ANOVA. Comparison of
HROHT with POAG was made using the non-parametric Mann Whitney test after
examination of the data showed a skew distribution. Correlations were performed for
men and women separately and correction was made for age.
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D: Peripheral Blood Flow: Laser Doppler Flowmetry
To investigate peripheral blood flow this study used the Periflux PF2 laser Doppler
flowmeter (Perimed, Sweden) with a 2mW HeNe laser of wavelength 632.8nm. This
machine utilises the Doppler shift to measure peripheral microvascular perfusion. As
explained in the previous section when a beam of laser light strikes a moving object,
such as a red blood cell, it undergoes a change in frequency known as the Doppler shift.
The magnitude of this shift is used to calculate blood flow velocity. The instrument then
calculates the blood cell flux in arbitrary units by multiplying the number of red blood
cells moving in the measured volume of tissue by the mean cell velocity. This flux
represents the blood cell flow through the microvasculature from the arterial to the
venous side. It is integrated over the entire measured volume of tissue - a hemisphere
with a radius of approximately 1mm.
The probe of the LDF was placed against the pulp of the middle finger avoiding undue
pressure and kept in position so that the signal indicator remained green. The baseline
flow (flux) was recorded once a steady recording was seen on the printout. The hand
was then immersed in warm water at 40 °C for 2 minutes, wrapped in a towel to prevent
heat loss and the flow monitored until a maximum value was noted. After approximately
10 minutes the hand was placed in ice cold water at 4 °C for 10 seconds and the flow
again monitored until a return to baseline. The following velocity parameters were
determined; baseline flow, maximum flow(warm), minimum flow(cold), time to recover
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to baseline flow after cold immersion, and ratios ofmax:min, max:baseline, and
minrbaseline following the protocol described by Drance^.
For statistical analysis of the peripheral blood flow data we compared the results across
4 groups using Kruskal Wallis ANOVA because the data was not normally distributed.
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Figure 12: Printout from Laser Doppler Flowmeter (fingertip)




A: Pulsatile ocular blood flow
Demographic data for all subjects are shown in tables 5 and 5a. A history of
hypertension, vasospasm (migraine or Raynaud's disease), smoking and the presence of
a family history of glaucoma was recorded based on the answers given by the subjects to
the questionnaire (see appendix C). There was no significant difference between the
groups in gender, axial length or refractive error (one-way ANOVA). Patients were
asked about history of smoking, vasospastic diseases (Raynauds disease and migraine)
or hypertension and no significant difference was found between the groups in these
variables. There was a significant difference in age (p=0.02) and the Bonferroni test
indicated that this lay between the glaucoma patients and low risk OHT, glaucoma
patients being significantly older. Adjustment was therefore made for age in group
comparisons using partial correlation. Glaucoma patients and high risk OHT had very
similar levels of intraocular pressure (average seated IOP 28.6mmHg and 28.5mmHg
respectively). Perfusion pressure (2/3MAP-Max IOP) was significantly lower in both
POAG and high risk ocular hypertension (HROHT) than in normals (p=0.001). This was
due to higher IOP in POAG and HROHT, mean arterial pressure (MAP) being no
different between the groups.
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Table 5 Demographic data: mean values(SD)
Variable POAG HROHT LROHT normal p value
n=24 n=27 n=24 n=23
Age (years) 68.8(10) 64.8(10) 60.0(11) 64.7(8) 0.02
IOPmax (mmHg) 29.9(4.3) 29.4(3.2) 23.4(1.6) 16.2(2.3) <0.001
IOPav (mmHg) 28.6(4.2) 28.5(3.0) 22.3(1.5) 16.0(2.3) <0.001
AxLength (mm) 22.9(0.9) 22.7(1.0) 23.0(1.2) 22.6(0.8) 035
SphEquiv (DS) 0.54(2.3) 1.1(2.1) 0.44(2.4) 0.76(1.5) 0.72
Sitting perfusion
pressure(mmHg) 47.7(13.2) 48.8(13.6) 53.3(8.9) 59.3(10.9)
0.004
Lying perfusion
pressure(mmHg) 88.0(18.8) 86.3(20.6) 88.6(13.6) 96.9(15.6)
0.16
MD(dB) -14.0(9.3) -1.25(2.3) -0.78(23) <0.001
CPSD (dB) 7.6(3.8) 1.9(1.1) 1.56(13) <0.001
Sex(F/M) 12/12 8/19 14/10 15/8 0.06
Hypertension
(N/Y)
22/2 22/5 19/5 21/2 0.47
Vasospasm (N/Y) 19/5 20/7 20/4 16/7 0.70
FamHx (N/Y) 15/9 18/9 16/8 18/5 0.68
Smoker (N/Y) 19/5 20/7 20/4 21/2 0.46
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IOPav * * * * * <0.001
IOPmax * * * * * <0.001
MD * * * <0.001
CPSD * * * <0.001
sitPP * * 0.004
* signifies a significant difference lies between the groups shown .
KEY: Table 5 and 5a
lOPmax maximum intraocular pressure on phasing
lOPav average IOP on phasing
AxLength axial length
MD mean deviation on field testing with Humphrey 24-2
CPSD corrected pattern standard deviation with Humphrey 24-2
F/M female/male
N/Y no/yes
sitPP Sitting perfusion pressure = 2/3 mean arterial pressure - maximum IOP
SphEquiv (DS)= spherical equivalent refractive error (dioptres sphere)
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Sitting, standing and lying POBF (Table 6)
Table 6 shows results of a one-way ANOVA comparing pulsatile ocular blood flow
parameters and blood pressure readings across the four groups. There were significant
differences between the groups in all positions (table 6a). In general normals had
significantly higher mean POBF and pulse volume (PV) when compared to high risk
ocular hypertensives and glaucoma patients. Glaucoma patients had the lowest POBF
and PV in all positions. There were no significant differences in pulsatile ocular blood
flow between POAG patients and high risk ocular hypertensives.
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Table 6 Sitting, lying and standing POBF (mean and SD)
High risk Low risk
Variable POAG OUT oirr Normals p value
n=24 n=27 n=24 n=23
SitPOBF(pl/min) 491(174) 551(250) 732(227) 846(284) <0.001
SitPA(mmHg) 2.4(0.8) 2.9(1.4) 33(1.1) 2.9(1.2) 0.08
SitPV((l) 33(1.1) 3.9(2.0) 5.1(1.5) 6.4(2.5) <0.001
SitSBP(mmHg) 156(25) 157(28) 152(16) 155(22) 0.86
SitDBP(mmHg) 85(10) 88(14) 86(9) 85(13) 0.87
Sitpls 70(10) 70(12) 70(8) 66(10) 036
SitMAP(mmHg) 114(17) 116(21) 113(12) 113(15) 0.91
StdPOBF 501(151) 568(201) 683(203) 848(283) <0.001
StdPA 23(0.7) 2.7(1.2) 2.9(0.9) 23(1.2) 0.19
StdPV 3.1(1.1) 3.7(1.7) 4.6(1.4) 5.9(2.6) <0.001
StdSBP 151(23) 156(30) 150(20) 150(22) 0.74
StdDBP 88(10) 92(13) 89(9) 90(13) 0.64
Stdpls 76(12) 74(11) 76(10) 72(12) 0.58
StdMAP 116(14) 117(21) 114(13) 117(21) 0.93
LyPOBF 471(156) 499(190) 631(203) 777(272) <0.001
LyPA 2.5(0.8) 2.9(1.2) 3.1(1.6) 2.8(1.2) 0.22
LyPV 3.4(1.2) 3.8(1.5) 4.8(1.6) 6.5(2.8) <0.001
LySBP 153(21) 155(28) 146(16) 146(22) 037
LyDBP 85(11) 86(12) 81(11) 82(14) 035
Lypls 66(9) 64(10) 66(9) 62(9) 0.29
LyMAP 111(15) 113(21) 105(12) 106(19) 0.41
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* * * * <0.001
SitPV * * * <0.001
Std
POBF
* * * * <0.001




Ly PV * * * <0.001
KEY: Table 6 and 6a
Prefixes: Sit = sitting Std = standing Ly = lying (supine)
POBF pulsatile ocular blood flow
PA pulse amplitude
PV pulse volume
SBP systolic blood pressure
DBP diastolic blood pressure
MAP mean arterial blood pressure
Pis radial pulse, beats per minute
137
Gender and POBF (Table 7 and Figure 13)
Females had significantly higher POBF than males (malerfemale difference after
adjusting for group p=0.009, two-way ANOVA). This is shown in table 7 and figure 13
and has been noted by others 4,9,10, Gender differences present in our groups which
may have contributed to this finding were a higher pulse rate in females in all groups,
significant only in POAG subjects (p=0.02), and a higher mean level of IOP in males in
all groups (again this difference was significant only in the POAG group, p=0.02).
Table 7 Gender differences in POBF(jil/min): mean(SD)

















Male/ female difference overall p=0.009
(Two way ANOVA corrected for group)
138

















Error bars show 95% CI ofmean
Male/Female difference after correcting for group, p=0.009 (2 way ANOVA)
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Postural change in POBF (Table 8)
In normal subjects it has been observed that the POBF falls on changing position from
sitting to lying down 11. This was found to be the case generally with our subjects but
there was a difference between the groups in the magnitude of change.
In table 8 the postural change in POBF is expressed as a percentage of the sitting value
in each group. Primary open angle glaucoma patients showed the smallest reduction in
mean POBF (3.8%) while low risk ocular hypertensives had the largest (13.7%). Using a
paired Student's t-test the difference in POBF from sitting to supine position was
significant (p<0.05) in the normal, low risk and high risk OHT patients but not in the
POAG group.











n=24 490(174) 471(156) -19 -3.8 030
HROHT
n=27 550(251) 499(370) -51 -9.2 0.03
LROHT
n=24 732(227) 631(203) -101 -13.7 0.001
Normals
n=23 846(283) 777(272) -69 -8.1 0.02
* change expressed as a percentage of sitting value
f paired students t-test comparing sitting POBF with lying POBF
140
Postural change in IOP and blood pressure (Tables 9,10 and 11)
Maximum and minimum intraocular pressure were recorded in sitting and supine
positions with the POBF machine. These readings were used to examine postural change
in maximum IOP. Results are shown in table 9. Primary open angle glaucoma and
HROHT subjects showed a small increase in maximum intraocular pressure on lying
down (+2.2% and +0.7% respectively). Low risk ocular hypertensives showed no
change and normals had a small reduction in max IOP on lying down (-3.5%). None of
these differences were statistically significant, however the result is supported by
numerous reports in the literature describing similar findings; i.e. a larger increase in
IOP on lying down in POAG and ocular hypertension than in normals 12-14












n=22 27.3(3.6) 27.9(4.3) +0.6 +2.2% 031
HROHT
n=27 28.7(2.5) 28.9(2.8) +0.2 +0.69% 0.66
LROHT
n=24 24.5(2.9) 24.5(2.4) 0 0 0.89
Normals
n=23 16.7(2.8) 16.1(2.8) -0.6 -3.5% 0.07
* change expressed as a percentage of sitting value
t paired students t-test comparing sitting IOP with lying IOP
NB: IOP values from OBF pneumotonometer
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Mean arterial blood pressure did not differ significantly between the groups in any
position (table 2). All groups showed a small decrease in MAP on lying down. This fall
was slightly larger in LROHT and normals (7% and 5.5%) than in HROHT and POAG
(2.6% and 3.1%) (table 10).
Table 10:







POAG 114(17) 111(15) -3.5(13.9) -3.1% 0.227
HROHT 116(21) 113(20) -3.0(10.6) -2.6% 0.156
LROHT 113(12) 105(12) -8.0(9.7) -7% 0.001
Normals 113(15) 107(19) -6.2(10.7) -5.5% 0.011
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The perfusion pressure was calculated for sitting and supine positions for each group as
follows:
Sitting perfusion pressure was calculated as 2/3 sitting MAP -sitting IOP.
Supine perfusion pressure was calculated as supine MAP -supine IOP.
Brachial MAP is reduced by one third in the calculation of sitting perfusion pressure to
allow for a reduction in ophthalmic artery pressure due to the elevated position of the
eye relative to the arm when seated. All groups had a moderately large increase in ocular
perfusion pressure on lying down. The increase was approximately 38mmHg in all
groups. Proportionally this change ranged from 65.5% in normals to 79.6% in high risk
OHT.
Table 11:








N=22 49.9(12.5) 88.0(18.8) 38.1(6.8) +76% <0.0001
HROHT
N=27 48.0(13.9) 863(20.6) 38.2(6.9) +79.6% <0.0001
LROHT
N=24 50.7(9.5) 88.6(13.6) 37.9(4.5) +74.7% <0.0001
Normals
N=23 58.6(10.1) 96.9(15.6) 38.3(5.8) +65.3% <0.0001
NB: maximum IOP reading from OBF machine used for calculation of perfusion
pressure in both positions.
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Comparing the absolute levels of postural change in IOP, POBF andMAP there was no
significant difference across the four groups although the trend for a larger positive
change in IOP and smaller postural change in POBF and MAP in glaucoma was evident
(table 12).











sitting IOP 24.9(3.3) 25.8(2.4) 21.6(2.0) 13.7(2.4)
<0.001
Maximum
sitting IOP 27.3(3.6) 28.7(2.4) 24.7(2.7) 16.7(2.8)
<0.001
Minimum
lying IOP 25.4(4.2) 26.0(2.6) 21.3(2.1) 13.3(2.5)
<0.001
Maximum
lying IOP 27.9(4.3) 28.9(2.8) 24.5(2.5) 16.1(2.8)
<0.001
AIOP
(min) 0.45(2.2) 0.19(1.65) -0.23(1.3) -0.51(1.37)
0.239
AIOP
(max) 0.58(2.5) 1.15(1.79) -0.18(1.5) -0.63(1.60)
0.189
AMAP -3.5(13.9) -3.0(10.6) -8.0(9.7) -6.3(10.7) 0366
APOBF 19.67(90.4) 51.2(116.9) 101.2(134) 69.3(129.9) 0.124
Key: A = supine value -sitting value




Correlations (tables 13 to 17)
Although the gender distribution across the 4 diagnostic groups did not differ
significantly there was a preponderance of women in the normal group and an excess of
men in the high risk OHT group (table 5). Because of this and the finding of higher
POBF in women (table 7) correlations were undertaken for men and women separately
to avoid skewing of the result.
Correlations with POBF were very similar for both sexes.
In men (table 14) sitting and lying pulse amplitude and pulse volume correlated with
radial pulse rate in both positions. Lying POBF correlated with sitting perfusion pressure
(c=0.33, p=0.02).
In women (table 13) the same correlations were present with the addition of significant
negative correlation between axial length and POBF and PA in both positions. The same
negative association was present in men but not to a significant extent.
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Table 13











































































































































c= Pearson's correlation coefficient
p= p value, shown bold if < 0.05
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Table 14





































































































































































































































































































Taking all subjects together (table 15) there was a strengthening of the correlations seen
in tables 13 and 14. In addition the positive association between sitting systolic blood
pressure and POBF became significant (c=0.20, p=0.05) and a negative correlation was
seen between lying diastolic BP and sitting PA and PV. There was a significant positive
correlation between perfusion pressure and sitting POBF, lying POBF and lying PV.
This may reflect a relationship between IOP and POBF since no significant correlation
was seen between MAP and POBF. Increasing axial length was associated with
reductions in all POBF parameters in the full group.
Separating the groups by diagnosis (table 16) a significant correlation was seen between
Goldman IOP and seated POBF in the POAG group (r=-0.43, p=0.03) but not in the
other groups. The magnitude of postural change in POBF (APOBF) was found to
correlate with sitting POBF in the three groups with raised intraocular pressure but not
in normals. No significant association was found between visual field result (MD and
CPSD) and sitting POBF in POAG or ocular hypertension.
The magnitude of the postural change in maximum IOP was related to average IOP,
sitting POBF and to the change in POBF (table 17). In other words higher IOP and lower
POBF were associated with a bigger increase in IOP on lying down across all subjects.
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Table 16















































IOPav = average IOP on phasing
APOBF = postural difference in POBF
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Table 17
Correlations with postural change in IOP (AIOP)











Axial length -0.29 -0.32
0.09 0.07
Sitting POBF -0.22 -0.37
0.21 0.04
Sitting PV -0.18 -0.32
0.32 0.07
Lying PA -0.02 -0.01
0.89 0.96
*IOP measured with Goldmann tonometer
NB: Postural change calculated using sitting and
lying IOP (maximum and minimum) from OBF machine
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Treatment and POBF (Table 18)
Details of topical treatment used in the reviewed subjects are in tables 3 and 4 (chapter
2.1). There was a significant reduction in IOP in treated subjects. Treated POAG
patients (n=14) had a mean seated pre-treatment IOP (Goldman tonometry) of
29.1mmHg falling to 21.1mmHg on treatment (p=<0.001). Ocular hypertensive subjects
(n=l 1) had a mean pre-treatment pressure of 27.5mmHg falling to 21.4mmHg on
treatment (p=<0.001). Treated POAG patients showed a significant fall in seated mean
arterial pressure (112mmHg to 99mmHg, p=0.03) and also in supine pulse amplitude
(2.6pl to 2.2pl, p=0.002). Ocular hypertensive subjects showed the same pattern with
significant drops in both sitting MAP (120mmHg to 113mmHg, p=0.05) and supine
pulse amplitude (3.3pi to 2.8pl, p=0.008). Both OHT and POAG subjects showed a non
significant increase in POBF after treatment. Results from OHT and POAG groups were
combined as numbers were small and the groups were alike in the pattern of changes. In
the combined group (table 18) there was a significant increase in mean POBF on
treatment (589.9pl/min to 670.8pl/min; p=0.02), an increase in mean sitting pulse
volume (4.01pi to 4.77pl, p=0.008) and the decrease in mean supine pulse amplitude
became more significant (2.97pl to 2.48pl, p<0.001).
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Table 18
Effect of treatment on POBF
OHT and POBF combined; 25 pairs
Pre-treatment Post-treatment P value*
Average






POBF 595.4(265.7) 671.5(208.3) 0.029
Sitting
PA 3.0(1.3) 2.8(0.8) 0.228
Sitting





SBP 156.8(29.5) 149.4(29.7) 0.021
Sitting
DBP 87.2(13.3) 84.4(14.0) 0.061
Sitting




POBF 543.6(202.3) 553.1(178.9) 0.715
Lying
PA 3.01(1.1) 2.5(1.0) <0.001
Lying





SBP 154.4(28.1) 147.7(25.9) 0.010
Lying
DBP 84.8(13.0) 83.4(11.50 0.418
Lying
MAP 110.8(20.3) 107.5(10.9) 0.167
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Postural changes after treatment (tables 19-21)
In treated subjects with pharmacologically lowered IOP the magnitude of change in
POBF on lying down increased and became significant in POAG and of increased
significance in OHT (p<0.0001, table 19) although the mean seated POBF was still
lower than that seen in the normal group at the initial visit (table 6).
The postural change in IOP remained insignificant in both groups after treatment (table
20). When subjects with treated IOP below 21mmHg were selected (mean post treatment
IOP =18mmHg, table 21) mean values suggested possible conversion to a small decrease
in IOP on lying down as seen in normals (table 9) but numbers were to small to draw
any conclusions from this.
Table 19





















753(225) 605(191) -148 -19.6 <0.001
♦paired Student t test
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Table 20























22.6(3.2) 22.5(5.1) -0.1 -0.004 0.92
*paired Student t test
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Table 21
Effect of treatment on postural change in IOP
(cases with treated IOP <21)













(27.33)* 27.4(2.2) 27.6(3.2) +0.27(2.3) +0.98% 0.738
Post
treatment
(18.00)* 19.4(1.8) 18.8(3.5) -0.64(3.1)
-3.0% 0.550
Student t test
*average Goldman IOP for the group (mmHg)
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B: Retinal Scanning Laser Doppier Flowmetry
All groups (table 22 A-E)
Significant technical difficulties were encountered when trying to obtain clear images of
the optic disc and retina for analysis. Many patients were unable to maintain steady
fixation for the required length of time and images from approximately one third of
subjects had to be discarded for this reason. Demographic details were rechecked for the
reduced groups and no significant differences were found. Mean ages of the groups were
POAG 66.6(10.9) yrs, HROHT 61.6(8.9) yrs, LROHT 57.9(10.0) yrs, and normal
63.4(8.3)yrs, (p=0.12).
The images for analysis were divided into 5 areas (see fig 11, page 125). Nasal retina
(area 1), nasal neuroretinal rim (area 2), optic cup (area 3), temporal neuroretinal rim
(area 4 ), and temporal retina (area 5).
In the nasal retina minimum velocity (p=0.031) and minimum flow (p=0.044) were both
significantly lower in LROHT than in HROHT (22A).
There were no significant differences between the groups in blood flow at the nasal
neuroretinal rim (22B) although difficulties obtaining reliable measurements from this
area in several images due to crowding of large blood vessels led to further reduction in
group size.
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At the optic cup (22C) measurements of minimum velocity and minimum volume were
both significantly lower in POAG than in HROHT (p=0.051 and p=0.Q33).
At the temporal neuroretinal rim (22D) POAG subjects again had significantly lower
maximum volume than HROHT (p=0.042).
In the temporal retina (22E) minimum velocity was significantly higher in normals than
in LROHT (p=0.021) and maximum and minimum flow were both significantly higher
in POAG than in LROHT (p=0.09 and p=0.020).
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Table 22














25.45 (6.02) 25.95 (5.95) 26.61 (5.9) 27.87 (6.65) 0.478
Min volume 14.43 (3.58) 16.84(3.19) 15.12(3.1) 16.48 (4.66) 0.277
Max
velocity
1.84 (0.50) 1.80(0.48) 1.71 (0.50) 1.79(0.37) 0.486
Min
velocity
































volume 16.76(5.14) 24.41(11.2) 16.62 (8.3) 19.27 (4.98) 0.125
Min volume 10.22 (3.23) 15.62 (6.36) 11.21(4.9) 13.25 (3.06) 0.075
Max






































volume 15.12(5.32) 23.72(12.7) 20.20 (6.81) 20.37 (7.68) 0.100
Min volume 7.49(1.98) 12.41 (8.22) 8.67(2.14) 11.09 (5.28) 0.033
Max
velocity 1.08(0.32) 1.57(0.66)
1.26 (0.42) 1.21 (0.36) 0.196
Min
velocity
































volume 15.99(4.15) 21.46 (5.75) 15.27(1.46) 20.16(6.48) 0.042
Min volume 12.11 (2.35)
14.72
(94.79)
13.77 (2.47) 13.07(4.17) 0.232
Max
velocity 1.42(0.49)
1.76 (0.59) 1.52(0.32) 1.55(0.42) 0.403
Min




































26.74 (8.82) 25.06 (4.25) 23.59(2.80) 26.65 (4.92) 0.191
Mill volume 15.57(6.19) 15.52 (5.23) 14.2(2.78) 15.09 (3.80) 0.700
Max

























Flow = distance travelled by all moving red blood cells
Volume = number of moving red blood cells
Velocity = mean red cell speed
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POAG vs HROHT (Table 23)
In comparing POAG with HROHT most differences were noted at the optic cup where
all readings were higher in HROHT. A significant difference was seen in maximum flow
(p=0.03), minimum volume (p=0.016), maximum velocity (p=0.045), minimum velocity
(p=0.016) and minimum flow (p=0.016).
At the neuroretinal rim (NRR) readings were again higher in HROHT. Significant
results were seen for maximum volume (p=0.043) and minimum volume (p=0.029) at
the nasal NRR and for maximum volume (p=0.010) at the temporal NRR.
In contrast significantly higher readings were seen for POAG in the temporal retina,
minimum velocity (p=0.014) and minimum flow (p=0.022) were both higher in POAG
than in HROHT and all other parameters in this area were increased to a nonsignificant
extent in POAG compared to HROHT.
Supplementary analysis of correlation of SLDF results with other parameters is recorded
in Appendix B (page 221)
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Table 23




POAG (15) hroiit (17) P value
Max volume 25.45 (6.02) 25.95 (5.95) 0.806
Min volume 14.43 (3.58) 16.84(3.19) 0.109
Max velocity 1.84 (0.50) 1.80 (0.48) 0.678
Min velocity 1.01 (0.31) 1.12 (0.29) 0.317
Max flow 523.73(147.7) 530.89 151.9) 0.955
Min flow 290.49 (98.6) 316.08 (85.6) 0355
Nasal rim
POAG (11) HROHT (14) P value
Max volume 16.76(5.14) 24.41 (11.20) 0.043
Min volume 10.22 (3.23) 15.62 (6.36) 0.029
Max velocity 1.77 (0.63) 2.07(1.03) 0.565
Min velocity 1.09 (0.38) 1.37 (0.70) 0.443
Max flow 512.68(189.7) 630.40 (347.5) 0.547
Min flow 308.84(110.4) 396.98 (214.5) 0.511
Optic cup
POAG (14) HROHT (16) P value
Max volume 15.12(5.32) 23.72(12.70) 0.034
Min volume 7.49(1.98) 12.41 (8.22) 0.016
Max velocity 1.08(0.32) 1.57(0.66) 0.045
Min velocity 0.59 (0.25) 0.98 (0.48) 0.016
Max flow 295.87 (125.9) 446.34 (200.5) 0.056




POAG (14) HROHT (17) P value
Max volume 15.99 (4.15) 21.46 (5.75) 0.010
Min volume 12.11 (2.35) 14.72 94.79) 0.088
Max velocity 1.42 (0.49) 1.76 (0.59) 0.121
Min velocity 1.14 (0.32) 1.15(0.51) 0.889
Max flow 407.78 (147.7) 521.25 (187.4) 0.088
Min flow 321.11 (92.8) 343.71 (161.4) 0.905
Temporal retina
Temp, retina POAG (15) HROHT (17) P value
Max volume 26.74 (8.82) 25.06 (4.25) 0.925
Min volume 15.57(6.19) 15.52 (5.23) 0.509
Max velocity 1.94(0.78) 1.63 (0.23) 0.361
Min velocity 1.07 (0.26) 0.85 (0.29) 0.014
Max flow 571.23 (248.5) 474.92 (79.9) 0361
Min flow 302.12 (77.7) 243.18(90.4) 0.022
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C: Haematology
All groups (Table 24)
Kruskall Wallis ANOVA was used to compare haematology results across the four
diagnostic groups. Beta-thromboglobulin, D-dimer and prothrombin fragment F 1&2 did
not vary significantly between the groups.
Manual fibrinogen was highest in LROHT (2.85+0.51 g/1), intermediate in POAG and
HROHT and lowest in normals (2.47±0.43g/l, p=0.048). LROHT differed significantly
from the normal group. Haematocrit and platelets were highest in POAG and lowest in
normal subjects. This difference was significant for platelets (p=0.027) and of borderline
significance for haematocrit (p=0.056). All values other than prothrombin fragment
F1&2 (PF1&2) were within the normal range for all groups. PF1&2 was elevated in
POAG and LROHT and at the upper limit of normal in HROHT and normals.
Demographic data was reviewed for the appropriate groups. A significant difference in
age (p<0.05) was seen between LROHT (59yrs+/-10)) and POAG (69yrs+/-10). Neither
POAG nor LROHT differed significantly from the other two groups with respect to age.
Correction was made for age in the statistical analysis of haematology results.
There were no other significant demographic differences between the groups other than
the expected ones for IOP and visual field result (MD and CPSD).
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Table 24
Haematology Results. 4 groups
Mean (standard deviation)
Normal range in italics










































































POAG HROHT LROHT normal
Total
cases
24 27 24 23
Beta-tg 2 1 3 2
fibrinogen 0 2 1 3
Ddimer 1 0 1 2
PF1&2 1 0 1 2
Platelets 1 1 1 3






Results were excluded if level was excessively high (>150)
indicating activation of platelets secondary to traumatic
venepuncture or transport.
One LROHT and one POAG had very high results suggestive of
artefact or problems with processing, 2 HROHT had no
fibrinogen result returned from the lab for unknown reasons.
One HROHT and one POAG had no FBC taken, one LROHT had
clotted FBC, and one POAG had very high haematocrit which
appeared to be artifactual as repeat testing one month later gave a
normal result.
Two normal subjects had no blood taken and one additional full
blood count result was missing from the lab report for unknown
reasons.
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A number of haematology results were missing from the analysis, the reasons for this are
shown in table 25.
POAG vs HROHT (Table 26)
No significant differences were found between HROHT and POAG although all results
were higher in POAG than in HROHT and borderline significance (p=0.056) was seen
for the difference in platelets and PF 1&2.
Supplementary analysis of the correlation of haematology results with other parameters



















































D: Laser Doppler finger blood flow
All groups (table 27)
Analysis of the demographic data for the groups found no significant differences other
than that in age (p=0.02) between POAG (68.4 +/- lOyrs) and LROHT (59.6 +/- 1 lyrs).
Comparing all subject groups it was found that low risk ocular hypertensives had
significantly higher baseline blood flow than normals (p=0.010). There were no
significant differences in the level of fingertip blood flow after immersion in warm or
cold water, or in the length of time taken for recovery to baseline flow after cold
immersion.
POAG vs HROHT (table 28)
There were no significant differences between POAG and HROHT in the measurements
of fingertip blood flow.
Correlations
No correlation was found between the parameters of fingertip blood flow and other




Laser Doppler finger blood flow (All groups)







































































Missing cases: 1 HROHT due to lost data
1 LROHT due to unreadable tracing
1 POAG due to patient having to leave early
1 normal measurement not done
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Table 28
Laser Doppler finger blood flow
POAG vs HROHT













































A: Pulsatile ocular blood flow
Summary of results
This investigation has found that in the untreated state POAG patients and ocular
hypertensives with IOP above 25mmHg have significantly reduced POBF and pulse
volume compared to ocular hypertensives with an IOP of 25mmHg and below or normal
subjects. We found no significant difference in pulsatile ocular blood flow parameters
between POAG and high risk ocular hypertensives. Primary open angle glaucoma and
high risk OHT patients had a significantly lower ocular perfusion pressure than normals.
Glaucoma patients differed from the other three groups in showing an insignificant
postural change in POBF (reduction in POBF on lying down). There was an inverse
correlation between pulsatile ocular blood flow and axial length, and between pulse
amplitude (PA), pulse volume (PV) and radial pulse rate. There was positive correlation
between seated perfusion pressure and POBF in sitting and supine positions. A
previously recognised finding was confirmed in recording higher POBF in women than
in men across all the groups. Finally, in a group of patients who received topical
treatment, predominantly with betaxolol, a significant increase in POBF was seen
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associated with a significant fall in IOP and seated mean arterial blood pressure and no
change in perfusion pressure. The fall in POBF occurring when changing position from
sitting to supine became more marked in patients on treatment. In POAG the difference
became statistically significant, in OHT the change showed increased significance.
POBF and visual function
The theory and assumptions underlying pulsatile ocular blood flow measurement have
been explained in Chapter 2.2. Pulsatile ocular blood flow is the calculated change in
ocular volume over time derived from continuous measurement of the ocular pressure
pulse at the corneal surface. It is generally assumed that POBF is an indirect measure of
the volume of blood entering the choroid during systole because the choroidal
circulation accommodates up to 90% of the blood arriving at the eye in each cardiac
cycled In support of this it has been found that POBF is reduced in conditions
associated with choroidal atrophy such as high myopia^ and retinitis pigmentosa^.
Yin et al demonstrated choroidal atrophy in post mortem specimens of eyes with
primary open angle glaucoma l^so we might also expect to find reduced POBF in this
condition.
There is evidence that POBF is related to visual function. Paris et al recently found a
significant increase (approx. 30%) in both POBF and contrast sensitivity with no
associated change in IOP in a group of normal adults after taking the phosphodiesterase
5 inhibitor sildenafil 18. Sildenafil (Viagra) augments the action of nitric oxide by
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preventing degradation of cyclic GMP, producing vasodilation. Reduced POBF has been
found in normal tension glaucoma^, and in anterior ischaemic optic neuropathy^ the
reduction has been noted to be more marked in the worse affected eye in both
conditions.
In this study peripheral retinal function was assessed by standard visual field analysis
and central Snellen acuity was recorded. Only the POAG subjects had visual field
defects as defined by the inclusion criteria and it was therefore not possible to assess
more subtle differences in visual function in the other subjects. No correlation was found
between visual field loss (MD and CPSD) and POBF in the patients in this study (table
16).
Sources of Error
It has been established that POBF is influenced by many factors.
Age, intraocular pressure, axial length, heart rate and gender have all been shown to
have some effect on POBF measurements 4,9,16,19,20 Treatment has also been shown
to influence POBF although published results are conflicting 21-24 None of the patients
in this study were using, or had ever used topical antiglaucoma medication at their initial
visit. The groups were well matched for heart rate, blood pressure, axial length and
refractive error and correction was made for age. High risk ocular hypertensives and
POAG patients were well matched for IOP. Although there was no significant difference
in gender distribution across the four diagnostic groups there was a preponderance of
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females in the normal group and of males in the HROHT group and for this reason
correlations were calculated separately for men and women.
Results from the Ocular Hypertension Treatment Study have highlighted the importance
of central corneal thickness as a confounding factor in the measurement of IOP79.
Central corneal thickness was not measured in this study and differences in CCT may
have influenced the results presented here in two ways. Firstly in the IOP dependant
categorisation of patients into groups: OHT subjects have been shown to have on
average a thicker central cornea than normal producing an artifactual increase in
measured IOP. The true IOP of the OHT subjects in this study may therefore be slightly
lower than that recorded. The difference in mean CCT measurements between OHT and
normals has been found to be approximately 30 microns by Herman et al 76. Singh and
associates 77 reported similar findings with no difference in CCT between POAG and
normals. Bhan et al78 calculated that CCT could account for an increase of 0.23mmHg
intraocular pressure per 10 microns corneal thickness over a wide range of IOPs. Using
the above values as a guide the mean IOP of the OHT groups in this study might be
reduced by approximately lmmHg after correcting for CCT. While knowledge ofCCT
appears to be important in assessing an individual's risk of developing glaucoma it is
unlikely that the results of the group comparisons presented here are greatly influenced
by the absence of this data. Secondly, it is to be expected that POBFmay be influenced
by CCT in the same way as IOP because POBF data is derived from corneal
applanation. A thicker cornea may be more rigid and give rise to artificially low POBF
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readings in OHT. In summary, in the absence of detailed information about CCT it may
be that the OHT groups presented here have a true IOP slightly lower and POBF slightly
higher than that recorded, and are therefore less 'glaucoma like' than they appear. Based
on data available in the literature the magnitude of this error would appear to be small.
Oestrogen is thought to increase POBF^O and hormone replacement therapy (HRT) has
been found to reduce vascular resistance in the ophthalmic arterySl. The patients in this
study were not specifically asked about HRT so it is not known what proportion of
patients in each of the groups were taking HRT and to what extent it may have
influenced the results if at all. There was however a preponderance ofmen in the
HROHT group in comparison to the POAG group which had equal numbers ofmen and
women. This may have led to a comparatively lower average POBF in the HROHT
group. Other non-prescription drugs which have an effect on blood flow such as ginko
biloba may also have been taken by the subjects in this study but, as with HRT, patients
were not specifically asked about this type ofmedication and the effect on the results is
not known.
Another possible source of error in POBF measurement is operator variability. In an
attempt to reduce this all measurements were performed by one experienced operator
(JK) following the same protocol and using the same machine as was used by Butt in her
reproducibility study^.
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The Effect of Treatment
Twenty three of the twenty six patients reviewed were using the betaj selective
antagonist betaxolol. The three patients in whom betablockers were contraindicated were
using dorzolomide. Seven patients were on a second topical treatment in addition to
betaxolol (4 dorzolomide, 1 latanoprost, 1 alphagan and 1 pilocarpine).
The literature regarding the effects of betaxolol on ocular blood flow is inconclusive.
Beta2 receptors have been identified in the optic nerve head and anterior optic nerve in
addition to the trabecular meshwork and ciliary body where non selective beta blockers
such as timolol exert their maximum effect^. Stimulation of beta receptors associated
with blood vessels generally causes vasodilation and antagonists such as timoptol cause
vasoconstriction. Some authors have suggested that the betaj selective action of
betaxolol may have a beneficial effect on optic nerve head blood flow in comparison
with non selective beta blockers^. In addition to this, in vitro experiments using bovine
ciliary arteries have shown a direct vasorelaxant effect produced by beta blockers which
is not mediated by beta receptors and thought to be due to inhibition of calcium entry
into the cell. Some authors have claimed that this effect is more marked for betaxolol
than for other beta blockers^!. However Harris, in a recent review of the literature
concluded that there was no convincing evidence to support a clinically significant effect
of beta blockers on ocular blood flow distinct from the IOP effect^.
Dorzolamide is a carbonic anhydrase inhibitor and it is known to produce vasodilation in
addition to lowering IOP. Several studies have found increased ocular blood flow after
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topical dorzolamide as measured withCDI^ and scanning laser ophthalmoscopy^.
Schmidt et al found increased ocular pulse amplitude in POAG and normals after
dorzolamide^S. Pilocarpine and Latanoprost have not been found to have any consistent
effect on ocular blood flow although one study found hyperaemia of the anterior
structures of the eye in rabbits after latanoprost application^. Brimonidine is an alpha
agonist and as such might be expected to produce vasoconstriction. Although systemic
vasoconstrictive effects have been measured studies have not found any significant
alteration in ocular blood flow after brimonidine^O. The studies referenced above have
examined retrobulbar and optic nerve head blood flow after administration of IOP-
lowering drugs and have largely given inconclusive results. In recent years there have
been some publications looking at the effect of antiglaucoma medication on POBF.
Shaikh and Mars found a significant increase in POBF after pilocarpine in ocular
hypertensive subjects^. Geyer et al reported similar findings in normal subjects after
latanoprost^.
How these results compare with published findings
The normal results reported here fall within the normal range described by Fontana et al
in 19989. Pulse volume and POBF were found to be significantly reduced in both POAG
and high risk OHT compared to normals and low risk OHT. This result concurs with that
of Trew and Smith 11 who found no difference in POBF between OHTs with mean IOP
22.6mmHg (similar to that of the LROHT group) and normals. In comparing glaucoma
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patients with ocular hypertensives Trew and Smith found significantly lower POBF and
pulse amplitude in POAG. However the mean IOP of their OUT group was lower than
that of our low risk OHTs and their POAG patients were treated with timolol prior to the
study which may have had a bearing on the results 25. In a published paper based on the
research presented here, reduced POBF was found in POAG compared with untreated
OHT subjects 26. The patient groups in that study differed in that the OHT group
consisted of a mixture of high risk and low risk subjects and the POAG patients had
more severe mean visual field loss than the group under consideration here. Mean values
reported here for POBF parameters are consistently lower in POAG than in high risk
OHT although the differences are not significant. It may be that there is a genuine
difference between OHT and POAG which becomes smaller when high risk OHT are
selected i.e. OHT subjects become more glaucoma-like in terms of their POBF as the
IOP rises.
Bergstrand and associates 27 recently compared blood flow in untreated OHT and
POAG matched for IOP using color Doppler imaging (CDI). They found increased
resistive index and reduced end diastolic velocity in the central retinal artery in untreated
POAG compared to OHT. POBF has been found to correlate most strongly with the CDI
parameter peak systolic velocity (PSV) in the central retinal artery28. Bergstrand found
no difference between the groups in this parameter which concurs with the finding
presented here of no difference in POBF between HROHT and POAG.
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One of the most striking differences in POAG subjects found by this investigation was
in the postural change in POBF. While normal subjects and ocular hypertensives
demonstrated a fall in POBF on lying down of between 8.1% and 13.7% of the sitting
value (px0.05), POAG patients had an insignificant reduction of only 3.8% (table 8).
This picture changed to one resembling normal after topical treatment to lower IOP with
the treated postural change increasing to 15.6% in POAG (table 19). The sitting POBF
in treated POAG did not increase to normal levels but the mean treated IOP in the group
remained relatively high in this study (21.0mmHg).
The OBF machine records details ofmaximum and minimum IOP in addition to POBF
parameters. These measurements of IOP have been found by other researchers to
correlate well with Goldmann tonometry and were used in this study to calculate sitting
and lying perfusion pressure for the purpose of investigating postural changes.
Very small postural changes in mean IOP were found. There was a slight increase in
IOP in POAGs on lying down and a slight decrease in normals. These findings are in
agreement with those published by others^,29 but were not significant in this study.
The magnitude of change in maximum IOP on lying down (AlOPmax) was found to
correlate strongly with seated Goldman IOP and also with sitting POBF. In subjects on
treatment to lower IOP the increase in IOP on lying down became smaller although once
again the change was not significant (tables 20 and 21).
All groups showed an increase in perfusion pressure on lying down. This was
proportionally more in the groups with higher IOP due to their lower initial perfusion
pressure but did not differ significantly between the groups.
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Blood pressure and 1QP
A significant fall in blood pressure was seen in treated subjects. Systolic blood pressure
was significantly lower in patients on treatment in seated and supine positions and
diastolic blood pressure fell to a lesser (nonsignificant) degree. It is not known whether
these changes are the result of a systemic effect of topical beta blockers, the
consequence of reduced anxiety in subjects attending for follow-up, or if they represent
an interactive relationship between IOP and blood pressure.
Betablockers are effective antihypertensives when given systemically but theirmode of
action is not understood. They reduce cardiac output, alter baroreceptor reflex sensitivity
and block peripheral adrenoceptors. Some block plasma renin secretion and they may
also exert a central effect. Some systemic absorption of betaxolol might be expected to
occur when it is administered topically to the conjunctival sac and the expected
consequence of this would be lowering of blood pressure and slowing of the heart
rate94 However, Harris et al in a study investigating the effect of betaxolol on
perimacular blood flow found no change in brachial blood pressure after administration
of topical betaxolol in healthy subjects^.
The third possibility has been proposed in the past and there is evidence in the literature
to suggest that IOP may indeed exert some influence over blood pressure.
If IOP is elevated an increase in blood pressure will maintain a constant ocular perfusion
pressure according to the equation:
Seated perfusion pressure = 2/3 mean arterial pressure -IOP
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Because the formula for supine perfusion pressure is as follows:
Supine perfusion pressure = mean arterial pressure -IOP,
a larger increase in blood pressure is required in the sitting position to maintain the
status quo. After treatment the group presented here had a larger fall in sitting
MAP(p=0.008) than in supine MAP(p=0.167), a finding which tends to support the
theory that there is a link between blood pressure and IOP. Other researchers have
identified higher blood pressure in POAG patients. Wilson et al identified systolic
hypertension associated with POAOpO and systolic blood pressure was 'the variable
most related to IOP' in the Framingham Eye Study^l. Low blood pressure has been
identified as a risk factor for visual field progression in POACj32 but particularly in
NT(j33 possibly representing a failure of the balance between BP and IOP. Wagner et al
found evidence of angiotensin II synthesis in the choroid, RPE and neural retinal
Angiotensin II is a potent vasoconstrictor and stimulates aldosterone release, its
production by the eye is one possible mechanism through which the eye may influence
systemic blood pressure.
Very recently Polak et al published a paper reporting a significant association between
increased choroidal blood flow and higher blood pressure in a group of 318 healthy men
with normal or slightly elevated BP. Choroidal blood flow was assessed using fundus
pulsation amplitude and blood flow velocities in the posterior ciliary arteries^^. This
raises the possibility that increased systemic blood pressure may be a response to
reduced choroidal perfusion possibly triggered by the relatively ischaemic glaucomatous
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eye. The measured fall in blood pressure associated with lowering of IOP and increase in
choroidal blood flow could be explained by this hypothesis. However, as mentioned
before, in this study systemic effects of the topical p blocker betaxolol could also have
caused a reduction in blood pressure and it is not possible to draw conclusions about the
origin of the change from the data presented here.
The relationship between POBF and IOP
Some previous studies have failed to find a relationship between IOP and POBF in
normal eyes^-G^ jn 1996, Harris presented CDI data supporting the existence of
autoregulatory control of ocular blood flow in the presence of changing IOP in normal
subjects^. Subsequent studies using POBF^ and CDl^ have identified a loss of this
control in glaucoma patients.
In this study IOP was excluded from correlations across the four groups because it was
one of the variables restricted by the inclusion criteria, i.e. no glaucoma patients with
IOP below 21mmHg were included. Normal pressure glaucoma comprises up to 30% of
the glaucoma population and NTG subjects are known to have low POBF. The effect of
excluding this group would be to artificially emphasise the association between high
IOP and low POBF and for this reason IOP correlations were examined for each
diagnostic group separately.
Looking at the diagnostic groups separately a significant negative correlation was seen
between IOP and POBF in POAG but not in the other groups (table 16). This finding
tends to support the theory that there is a loss of autoregulatory control of blood flow in
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glaucoma and that IOP has a greater influence on choroidal blood flow in glaucomatous
eyes than in normals eyes. This theory is supported by the finding of James and Smith
who found a correlation between POBF and IOP in NTG patients which was not present
in a normal group matched for IOP82.
In studies on rabbits Gual et al demonstrated that an intact autonomic supply to the eye
helps to buffer IOP elevations induced by water loading or cephalic venous stasis. They
propose that this is through autonomic input to the ocular vasculature^.
One possible interpretation of the results presented here is that the choroid may perform
a central function in accommodating changes in ocular perfusion pressure in the normal
eye, not only in fight or flight situations as proposed by others^ but also on lying down.
The increase in ocular perfusion pressure which occurs on lying down will lead to an
increase in the nonpulsatile component of ocular blood flow, reducing the volume of
choroid available for pulsatile perfusion. The choroidal capacity in a healthy eye may be
enough to accommodate this significant reduction in pulsatile flow without
compromising function although postural studies have shown some reduction in retinal
function does occur on lying down which becomes more marked if a subject is tilted into
a head down position^. If the potential choroidal volume is effectively reduced by
raised intraocular pressure which increases resistance to choroidal filling^, by
vasospasm, or by the effects of ageing and atherosclerosis the ability of the eye to cope
with changes in perfusion pressure may be compromised. In glaucomatous eyes an
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already significantly reduced POBF is reduced further when the patient lies down. It
may be that this reduction is not enough to fully accommodate the increase in
nonpulsatile flow and a small increase in IOP ensues further compromising perfusion.
Regarding the differences between ocular hypertensives and glaucoma patients, ocular
hypertensives with IOP above 25mmHg show changes in pulsatile ocular blood flow in
the same direction as the glaucoma subjects but not to the same extent. The only
difference found between the two groups was in the response of POBF to changing
posture, the HROHTs having a larger and more 'normal' reduction in POBF on lying
down than the glaucoma patients perhaps suggesting that their choroid retains the
capacity to accommodate changes in perfusion pressure despite their elevated IOP.
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B: Scanning Laser Doppler Flowmetry
Summary of results
This investigation has found alterations in retinal blood flow in POAG and HROHT as
measured with scanning laser Doppler flowmetry (Heidelberg retinal flowmeter).
In the nasal retina the trend was for higher SLDF readings of velocity and flow in high
risk OHT. There was a significant difference between HROHT and LROHT in minimum
velocity and minimum flow in this area. At the nasal neuroretinal rim the trend once
again was for highest readings in HROHT although there were no significant differences
between the groups. At the optic cup the highest readings were seen in HROHT and the
lowest in POAG. This difference was significant for minimum volume and minimum
velocity. At the temporal neuroretinal rim HROHT had the highest readings for all
parameters and was significantly higher than POAG for maximum volume. In the
temporal retina there was a change in the pattern of results with a trend for highest
readings in POAG subjects in this area. POAG patients had significantly higher readings
than LROHT for minimum velocity, maximum and minimum flow in the temporal
retina. Comparing POAG with HROHT the same pattern was seen with higher readings
in OHT at the nasal rim, optic cup and temporal rim. POAG subjects had higher levels
of blood flow in the temporal retina. The difference between some parameters in each
area was statistically significant.
Taking all subjects together significant positive correlation was seen between systolic
BP and SLDF parameters at the nasal neuroretinal rim (maximum and minimum
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volume). For the reasons mentioned in the previous section correlations with IOP were
not carried out for the full patient group because of the restriction of IOP in the inclusion
criteria and the exclusion of glaucoma subjects with IOP less than 21 mmHg. There was
also positive correlation between age and SLDF in the nasal retina (maximum volume)
and in the temporal retina (minimum flow). There was no significant correlation
between SLDF and POBF or pulse. Taking all OHT and POAG subjects together a more
negative MD was significantly correlated with lower SLDF particularly at the optic cup,
there was a similar relationship between more positive CPSD and lower SLDF. In other
words worse visual field parameters were associated with lower SLDF readings at the
optic cup. Looking at POAG subjects alone no significant correlations were found. This
may be because the group size was small (n=15).
These results show evidence of reduced blood flow at the lamina cribrosa and temporal
neuroretinal rim and of increased flow in the temporal retina in untreated POAG
compared to HROHT subjects with a similar level of IOP.
Comparison with other studies
At the time of this investigation there was very little published data comparing OHT and
POAG and existing studies referred to normal subjects for comparison with OHT and
POAG. Michelson and associates compared POAG patients with normals and found
reduced blood flow at the lamina cribrosa and nasal and temporal retina in POAG 41.
Nicolela and associates, using SLDF, also found reduced blood flow at the lamina
cribrosa in POAG compared to normals with a non-significant increase in blood flow at
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the temporal neuroretinal rim in POAG. They found reduced flow at sites on the
temporal retina in POAG compared to normals. The subjects in their study were a
heterogeneous group including normal pressure glaucoma patients and two thirds of the
group were also on topical antiglaucomamedication^.
Bohdanecka et al found a highly significant correlation between the Heidelberg retinal
flowmeter parameter 'volume' at the optic nerve head and blood flow velocities in the
retrobulbar vessels measured with colour Doppler imaging (CDI), suggesting that
patients with altered blood flow in the retrobulbar vessels are likely to also have
alteration in their optic nerve blood flow as measured with SLDF. Many CDI studies
have found reduced flow velocities in the retrobulbar vessels in glaucoma*® ,44
The study reported here found no significant differences between normal controls and
POAG although mean results for POAG were consistently lower than the normal group
at the lamina and higher than normal at the temporal retina. Itmight be that with larger
groups this difference would become significant. The results presented here concur to
some extent with those previously published by others in that the group with normal
visual function (HROHT) had higher blood flow at the optic nerve head than the
glaucoma group.
The finding in this study of increased temporal retinal blood flow in glaucoma has not
been previously reported. Of all the 5 areas measured in this study (figure 11) the retina
was least likely to present problems due to limited space or large blood vessels, in
addition the images were taken focussed on the retinal vessels so lack of focus should
not have been a major source of error. Areas of peripapillary atrophy (PPA) were
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avoided when placing the sample square which may have produced higher flow readings
than those recorded in other studies. Blood flow was noted to be markedly reduced in
these areas and it may be that an average blood flow measurement for the entire area
including PPA would be reduced in POAG compared to normal, or thatmeasurements
taken at a set distance from the disc would include some peripapillary atrophy more
frequently in POAG than in normals.
In 1999 Roff et al reported a significant increase in blood volume, flow and velocity
measured with SLDF in the superior temporal quadrant of the peripapillary retina during
isoxic hypercapnia in normal subjects^. This raises the possibility that the findings
presented here represent an autoregulatory increase in blood flow in the glaucomatous
retina in response to e.g. an increase in pC02.
This study has found a correlation between worse visual field parameters and reduced
blood flow at the optic cup. This is in agreement with a recent study by Ciancaglini et al
who found a correlation between both MD and CPSD and SLDF parameters measured at
the lamina cribrosa in glaucoma patients^.
In contrast to previous studies the subjects in this investigation were not on any form of
topical or systemic vasoactive medication. While some authors have found that topical
treatment does not make a significant difference to ocular blood flow41»47j others have
demonstrated changes in blood flow produced by topical antiglaucoma medication
22,24,48 The possibility that treatment may produce changes in local distribution of
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blood flow or autoregulation remains and may account for the differences in the findings
of this study and those of others in which treatment was not excluded.
Reduced retinal blood flow may be a function of increased IOP 36. In previous studies
POAG patients have been compared with normal subjects and the groups have not been
matched for IOP41 >49,50 The intention in this investigation was to reduce the
confounding effect of this variable by comparing two groups matched for IOP and the
results may therefore reflect a truer, IOP independent, assessment of blood flow in
glaucoma.
Sources of error
We encountered several technical problems in our use of the SLDF. It was difficult to
obtain well focussed images without movement artefact particularly in elderly patients
with poor vision in the contralateral eye which interfered with fixation. The group sizes
for this investigation are therefore small and the results must be viewed with this in
mind. The most common reasons for omission of an image from the analysis were
movement artefact in the picture or poor focus. In the nasal and temporal neuroretinal
rim areas there were also problems obtaining reliable measurements due to crowding of
large blood vessels. In some cases it was not possible to place the enquiry square
without including a portion of a large vessel and in these cases measurements at the
neuroretinal rim were omitted. Nicolela and associates reported similar problems in their
study using the same machine42. These problems have been addressed in recent years
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with the development of image analyser software which combines optic disc topography
with SLDF perfusion images to give 'mean flow' results for selected areas^l.
In taking measurements from the images the placement of a 10 x 10 pixel square on the
temporal rim unavoidably includes an area of optic cup when the rim is thin. This
produces a tendency for results at the temporal neuroretinal rim to be artificially lower in
POAG than in subjects with a healthy optic disc. The 10 pixel square was used in this
study because previous researchers had used this size of sample area 41,42,52^
reliability and reproducibility studies relate to a 10 x 10 pixel square6,53 a similar
problem was encountered when taking measurements from the optic cup in OHT
subjects i.e. the sample area included neuroretinal rim if the cup was small and there was
a risk of artificially elevated blood flow readings in OHT. Images ofOHT subjects with
an optic cup too small to allow placement of the sample square were excluded in an
attempt to avoid this problem. Finally when focussing on the retinal vessels the floor of
the optic cup in POAG may be deeper and therefore further from the focal plane in
POAG than in OHT. This would tend to produce lower results in POAG at the optic cup.
In comparing POAG with OHT it is important to remember that OHTs are a
heterogeneous group containing some 'pre-glaucoma' patients. This study has not
attempted to differentiate between types of OHT but has simply compared two groups
with similar IOP one of which, the POAGs, have optic nerve damage producing
demonstrable visual field loss. It is therefore likely that the changes in blood flow
identified in this study relate to the damaged state of the optic nerve in POAG. It is also
possible that the difference between the two groups is reduced by the presence of
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preglaucoma patients in the OHT group as it is known that structural changes may occur
at the optic nerve head in ocular hypertension before the appearance of measurable field
loss.
Interpretation of results
The results presented here suggest that the choroidal and retinal circulation respond in
different ways in POAG with a decrease in choroidal blood flow as demonstrated by
reduced SLDF parameters at the lamina cribrosa in the glaucoma group, and an apparent
increase in retinal circulation as shown by the increased minimum velocity and flow in
the temporal retina.
The blood supply of the retina and choroid are anatomically different; the choroid
derives its supply from the short posterior ciliary arteries which also supply the lamina
cribrosa, and the retinal supply comes from the central retinal artery. There is also a
difference in the control mechanisms of these two vascular beds. The choroid receives
an autonomic nerve supply and studies have demonstrated increased choroidal blood
flow in response to parasympathetic stimulation 54 and reduced flow in response to
stimulation of the cervical sympathetic chain^S. in contrast the retinal vessels do not
have an autonomic supply and blood flow is autoregulated in response to local tissue
demand and accumulation ofmetabolites^.
These anatomical and physiological differences may help to explain the findings. A
relative reduction in parasympathetic activity in the choroid could produce reduced
choroidal blood flow due to unopposed sympathetic action leading to retinal ischaemia.
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In addition to causing damage to the photoreceptors and visual field loss this ischaemia
may also lead to a reactive autoregulatory vasodilation in the retinal vessels in response
to hypoxia or hypercapnia^.
Autonomic dysfunction has been suggested before as a possible underlying abnormality
in glaucoma 56. Jordan and associates demonstrated parasympathetic denervation
hypersensitivity to dilute pilocarpine in glaucoma patients 57 and several studies have
found reductions in both sympathetic and parasympathetic activity on autonomic testing
in both NTG58 and POAG patients59 60 Qne study reports an increase in sympathetic
activity and a decrease in parasympathetic activity in closed angle glaucoma61.
Autonomic neuropathy has also been suggested as an explanation for the reported
increased incidence of POAG found in diabetic patients62,63
Review of patients on treatment
SLDF images were taken on the review visit but the relatively small number of patients
reviewed combined with the difficulty obtaining good images and non-uniform




This study has identified some significant differences in haematological parameters
between the groups examined. Manual fibrinogen was found to be slightly higher in
ocular hypertension and POAG than in normals (P=0.048). The platelet count was also
higher in POAG and OHT than in normals (p=0.027) and there was borderline
significance for the difference between the groups in haematocrit (p=0.056) with higher
levels again seen in POAG and OHT. Other parameters measured (betathromboglobulin
(Ptg), D-dimer, and prothrombin fragment 1 and 2 (PF1&2)) did not differ significantly
between the groups. The mean level of prothrombin fragment 1&2 in the POAG group
was found to be elevated above the upper limit of the normal range, all other results
were within normal limits. Comparing POAG with HROHT mean levels of {3tg, manual
fibrinogen , D-dimer, PF1&2, platelets and haematocrit were all higher in POAG. This
difference was not significant for any measurement although borderline significance
(p=0.056) was seen for the difference in platelets and PF1&2.
Correlations were examined for males and females separately and correction was made
for age. In men a positive correlation was found for haematocrit with diastolic blood
pressure and for platelets with systolic BP. No relationship between blood pressure and
haematological parameters was found in females.
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Coagulation
There has been much research in recent years into the possible role of a hypercoagulable
state in the pathogenesis of glaucoma. Drance in 1973 reported an increased thrombotic
tendency in normal tension glaucoma (NTG) due to increased platelet adhesiveness or
abnormal euglobulin lysis time*>4. Conflicting findings were published by Joist et al 3
years later when they reported no difference in platelet function, blood coagulability or
fibrinolytic activity between NTG and normals matched for age and systemic vascular
disease^. Drance's team also failed to reproduce their original findings in a later
study****. O'Brien et al published findings from an investigation comparing clotting
parameters in POAG, NTG and normals**?. They found a significant (p<0.001) elevation
in prothrombin fragments 1&2 and D-dimer in POAG compared to both NTG and
normals, however the POAG group had higher systemic blood pressure and both POAG
and NTG had significantly more systemic vascular disease than normals. Of the
parameters measured in this investigation fibrinogen, D-dimer and PF1&2 are indicators
of coagulation.
In the coagulation pathway PF1&2 are released when prothrombin is converted into
thrombin. Thrombin acts on fibrinogen to produce fibrin. D-dimer is produced as the
terminal fragment in fibrin degradation following secondary fibrinolysis (figure 14).



































Figure 14: Platelet function and the clotting cascade
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In this study the groups under investigation do not differ significantly in their mean
systemic blood pressure, in the incidence of events signifying systemic vascular disease
or in the number of smokers in each group. The low risk ocular hypertensives were
significantly younger than the POAG subjects and there was a difference in gender
distribution between the groups although this difference was not statistically significant.
Differences in parameters which normally rise with age or are higher in men than in
women such as haematocrit and platelets may be accentuated with higher levels seen in
HROHT and reduced levels seen in normals (due to higher proportion of women) and
LROHT (due to younger age). A trend for higher levels of all parameters in POAG was
seen with a significant difference between the four groups in fibrinogen levels
(p=0.048). Although they did not differ from normals in this study POAG subjects had a
mean level of PF1&2 which was elevated above the normal range.
The subjects in this study were selected prospectively over 18 months with no specific
age or gender requirements. The exclusion of patients on vasoactive medication will
have produced a selection bias for patients with less systemic vascular disease. It is not
known whether a larger proportion of POAG subjects were excluded for this reason
because recruitment was initiated by several different doctors. Awareness of the
inclusion criteria for the study meant that only patients not on systemic medication were
brought to the attention of the investigator. It is possible that if patients had been
selected with no restrictions related to vasoactive medication the difference between
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normal and POAG may have been more marked. There is known to be an increased
prevalence of systemic hypertension among subjects with raised IOP ^1.
This investigation has therefore examined what is probably a subgroup of POAG and
OHT with relatively little systemic vascular disease. The slight increase seen in markers
of coagulation in POAG is in agreement with other studies^ and has the additional
benefit that the observations relate to groups that do not differ significantly in blood
pressure, IOP, or reported systemic vascular disease. Based on the results presented here
it seems likely that POAG is associated with mildly increased activation of the clotting
system such as is seen with increasing age or atherosclerosis.
Platelet function
Abnormal platelet function has also been identified as a possible contributing factor in
glaucoma. There have been numerous studies examining platelet function both in vitro
and in vivo. Hoygn et al reported an increased incidence of in vitro spontaneous platelet
aggregation in deteriorating glaucoma (POAG and NTG) compared to subjects with
stable glaucoma or ocular hypertension^. This finding was recently confirmed by
Matsumoto who found a higher incidence of abnormal platelet aggregation in both
POAG and NTG, more marked in the latter^.
In this study plasma levels of beta thromboglobulin (f5tg) were measured as an indicator
of in vivo platelet activity. Betathromboglobulin is contained in the alpha granules of
platelets and is released when platelets are activated. Elevated levels have been found in
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DVT, preeclampsia and some infections. At the time of this investigation no studies had
looked at levels of this protein in untreated POAG or OHT. No difference in plasma ptg
level was found in this study between glaucoma or OHT and normals however platelets
were significantly more numerous in the groups with higher intraocular pressure.
Viscosity
Plasma and whole blood viscosity have been found to be elevated in POAG by some
authors 50,72,73? not others^. Results can be difficult to compare due to the high
prevalence of confounding variables such as cardiovascular disease in the glaucoma
population and the use of different techniques to measure viscosity.
No specific investigation into viscosity was made in this study however two components
ofwhole blood which contribute to viscosity are haematocrit and fibrinogen. Fibrinogen
was found to be significantly elevated in POAG and LROHT in this study and a higher
haematocrit in POAG was of borderline significance.
Treatment effect
A number of glaucoma and ocular hypertensive subjects who were started on treatment
to lower IOP had repeat blood samples taken at a review visit (see appendix). No
significant differences were found either between HROHT and POAG post treatment or
in the measurements for the group before and after treatment although there was a
borderline reduction in platelets (p=0.06)
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In summary the findings presented here tend to support those already published in the
literature. Differences between POAG and normal may have been reduced by the
exclusion of subjects on systemic vasoactive medication as an unrestricted sample of
POAG may have contained a larger proportion of people with systemic vascular disease
than the normal group. Limited conclusions can be drawn from the results relating to the
treated group because treatment was not uniform, the mean treated IOP for the group
remained at the upper limit of normal and treatment was associated with a significant
drop in systemic blood pressure.
It may be that untreated glaucoma and ocular hypertensive subjects have mild activation
of the clotting cascade and a tendency to increased blood viscosity to an extent
compatible with increasing age or mild atherosclerosis. Topical treatment to lower
intraocular pressure would not be expected to have any great effect on rheology however
the attendant reduction in blood pressure whether due to systemic effects of betablockers
or a response to lower IOP may have a beneficial influence reflected in a non¬
significant reduction in clotting parameters. This theory is supported by the correlation
of platelets and haematocrit with systolic and diastolic blood pressure respectively in




This study found significantly increased baseline fingertip blood flow in low risk OHT
compared to normals. No significant differences were found between the groups in
blood flow after warm or cold provocation nor in the time taken to recover from
immersion in ice cold water.
The laser Doppler flowmeter used to measure peripheral blood flow in this study is
straightforward to use. Possible error may arise if the finger pulp is compressed by the
probe during measurement. Care was taken to ensure that this did not occur and all
measurements were performed by one experienced operator (JK). Another factor which
may affect peripheral blood flow is ambient temperature. All measurements were made
in the same windowless room and the room temperature was recorded. There was no
variation in temperature in excess of 1°C.
As mentioned before the exclusion of subjects on vasoactive medication will have led to
the selection of a group with less systemic vascular disease and it is not known ifmore
glaucoma patients than ocular hypertensives were excluded on these grounds. In
addition no information is available about the possible confounding presence of non-
prescribed drugs such as ginko biloba which may have a profound effect on peripheral
blood flow and vasospasm.
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Many previous studies have identified an increased vasospastic tendency in patients with
normal pressure glaucoma**. Others have found colder peripheries without frank
vasospasm in POAG. At the time of this study there were no publications investigating
peripheral blood flow in untreated ocular hypertension. The finding of increased
baseline blood flow in LROHT is unexpected and may simply relate to the younger age
of the LROHT subjects. In addition to this the incidence of reported vasospastic
symptoms (migraine or Raynauds) was higher in the normal group (43%) than in the
other groups (POAG 26%, HROHT 35% and LROHT 20%). Although this difference
was not statistically significant across the four groups itmay have had a bearing on the
results (Table 5). Another possible interpretation of the result is that ocular
hypertensives show relative peripheral vasodilation which occurs in response to a
reduction in ocular perfusion secondary to raised IOP. This ability to compensate for
reduced ocular perfusion pressure may be reduced or lost in subjects with higher IOP or
established glaucoma.
Vascular changes have been demonstrated in the eye in response to stresses imposed on
the peripheral vasculature^,75 an(j it js possible that a generalised vascular response
may result from changes in ocular perfusion.
The findings presented here are difficult to interpret due to the confounding variables of
age and differing incidence of vasospastic disorders between the groups, however it
raises interesting questions about the behaviour of the peripheral circulation in ocular




The main aim of this study was to compare ocular blood flow and related factors
influencing perfusion in groups of untreated ocular hypertensives and glaucoma patients
matched for IOP.
Differences between OHT and POAG which may be related to the presence of disease in
the glaucoma group were identified. There was a trend for lower POBF in glaucoma
compared to OHT although this was not statistically significant in this study itmay be
that with larger numbers it would become so. Both POAG and HROHT had significantly
lower POBF than normals. A difference was evident between HROHT and POAG in the
response of POBF to changing posture and in the distribution of blood flow in the retina
and optic nerve head as measured with scanning laser Doppler flowmetry. A
significantly higher temporal retinal blood flow was found in POAG suggesting possible
differences in the autoregulatory response between the two groups.
No difference was found between OHT and POAG with respect to clotting factors or
peripheral vasoreactivity. POAG had a small but significant increase in clotting
parameters and platelet count compared to normals and significantly increased
peripheral perfusion was found in low risk ocular hypertensives. The latter result may be
attributable to a younger mean age in the LROHT group.
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The findings of this study point to a disturbance in choroidal perfusion in POAG which
is at least in part related to IOP and present to a lesser extent in OHT subjects with IOP
over 26mmHg. The findings also suggest that there may be some degree of
decompensation of autoregulatory mechanisms in glaucoma which is not present in OHT
with a similar level of IOP.
Further research should look at the role of the choroid as a buffer accommodating
changes in ocular perfusion pressure and IOP. The possibility that the choroid is the
common endpoint at which intraocular pressure, vasospasm, atherosclerosis, autonomic
dysfunction and age exert their effect to produce glaucomatous optic atrophy deserves
further investigation and there may be therapeutic potential in drugs which modulate
choroidal perfusion in addition to those which act on intraocular pressure.
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2.6
Suggestions for future work
1. The role of the choroid as a buffer of fluctuations in IOP could be explored by
examining patients with damaged or reduced choroid in one eye. Comparison of postural
IOP fluctuations in fellow eyes of patients who have undergone treatment for choroidal
malignant melanoma in one eye may give information about whether the choroid is
involved in IOP homeostasis.
2. Follow-up studies of the ocular hypertensive group examined here may give
information about the number converting to POAG and allow retrospective examination
of blood flow results to determine if any differences existed in blood flow in these
subjects prior to the appearance of glaucomatous field loss.
3. Peripheral blood flow in ocular hypertension: Larger groups of ocular hypertensives
could be examined to determine whether they have a genuine increase in peripheral
blood flow associated with raised IOP.
4. Studies examining the shape of the ocular pulse in ocular hypertension may give
additional information about ocular elasticity and the ability of an eye to withstand
raised IOP. In this and in many other studies ocular hypertensive subjects were found to
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consistently have higher pulse amplitude than glaucoma patients. The significance of
this is not clear.
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Appendix A
Publications and Presentations arising from this thesis
'Pulsatile ocular blood flow in ocular hypertension and primary open angle glaucoma'
Kerr J, Nelson P, O'Brien C: Am J Ophthalmol 2003: 136:
'A comparison of ocular blood flow in untreated primary open angle glaucoma and
ocular hypertension.'
Kerr J, Nelson P, O'Brien C: Am J Ophthalmol 1998: 126:42-51
'Optic nerve and retinal capillary blood flow in in untreated primary open angle
glaucoma (POAG) and ocular hypertension (OHT)'
Kerr J M, O'Brien C: IOVS, March 15 1997, Vol 38, No 4, page s276
'Pulsatile ocular blood flow in untreated ocular hypertension and primary open angle
glaucoma'
Glaucoma Society 18th Annual Meeting, November 1997
Kerr J, O'Brien C. (presentation)
'Ocular blood flow in untreated primary open angle glaucoma and ocular hypertension'
Royal College of Ophthalmology Annual Meeting, May 1997
Kerr J, O'Brien C. (poster)
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'A comparison of Heidelberg retinal flowmeter results in untreated primary open angle
glaucoma and ocular hypertension'
Scottish Ophthalmological Club Meeting, March 1997
Kerr J, O'Brien C. (presentation)
'A comparison of Heidelberg retinal flowmeter results in untreated primary open angle
glaucoma and ocular hypertension'
Glaucoma Society 17th Annual Meeting, November 1996




SLDF Correlations (table A)
Data was examined for correlation between SLDF, POBF, visual fields, and systemic
haemodynamic measurements. In the full group of subjects comprising normals, OFTT
and POAG, significant correlation was seen between seated systolic BP and maximum
volume at the nasal NRR (c=0.321, p=0.024, n=49) and minimum volume at the nasal
neuro retinal rim (c=0.319, p=0.025, n=49). Age correlated with maximum velocity in
the nasal retina (c=0.285, p=0.022, n=64), and minimum flow in the temporal retina
(c=0.289, p=0.022, n=63).
Correlation with visual field was examined for OHT and POAG together. Results are
shown in table A. Mean deviation (MD) of visual field was positively related to blood
flow at the optic cup and negatively related to blood flow in the temporal retina.
Corrected pattern standard deviation (CPSD) was positively correlated withminimum
velocity and minimum flow in the temporal retina. No significant correlations were
found for SLDF with other parameters in POAG alone (n=15). POBF showed positive
correlation with minimum velocity in temporal retina and negative correlation with
minimum flow in nasal retina (table A).
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These results must be viewed with caution due to the large number of variables
compared. It is expected that some significant correlations may arise by chance. A
correction may be applied to the results to allow for this (Bonferroni) and it sets the level
of true significance at p=0.005. At this level there is no significant correlation found
between SLDF and the other variables measured.
Table A







































































































































































































































































































































































Significant correlations (px0.05) are shown bold.
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Haematology Correlations (Tables B and C)
Partial correlations were performed with correction for age examining the relationship of
haematocrit, platelets, fibrinogen and PF1&2, to other measured parameters. The results
are shown in tables B and C. Normal haematological reference values for men and
women differ and there was an imbalance in gender distribution between the study
groups as noted before (there was a higher proportion of females in the groups with
lower IOP). For this reason results from men and women were examined separately. In
men systolic blood pressure correlated with platelets (c=0.32, p=0.052) and haematocrit





Correlations corrected for age
Males (n=35)
fibrinogen platelets haematocrit
Average C=0.247 0.091 0.041
IOP P=0.140 0.592 0.808
Maximum 0.297 0.091 0.520
IOP 0.075 0.593 0.759
Systolic 0.083 0322 0.219
BP 0.622 0.052 0.192
Diastolic 0.003 0.243 0371
BP 0.984 0.147 0.024
Sitting -0.072 0.178 -0.065
POBF 0.674 0.292 0.700
Sitting -0.080 0.213 -0.292




Correlations controlled for age
Females (n=40)
fibrinogen platelets haematocrit
Average C=0.097 0.254 0.165
IOP 0.540 0.104 0.295
Maximum 0.128 0.232 0.213
IOP 0.418 0.138 0.175
Systolic -0.020 0.034 -0.145
BP 0.895 0.831 0359
Diastolic 0.007 -0.078 -0.823
BP 0.963 0.622 0.602
Sitting -0.045 -0.162 -0.087
POBF 0.779 0.306 0.583
Sitting -0.075 -0.176 -0.122
Pulse volume 0.635 0.264 0.441
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There was no significant change found in haematological parameters in treated subjects.
Table D
Effect of Treatment on Rheology
Mean (standard deviation)
HROHT (n=10) and POAG (n=14) combined (24 pairs)
Parameter
Normal value













0.44-1.1 nmolsll 1.37(0.63) 1.43(0.84) 0.71
Platelets
150-350x1011 295.9(134.3) 269.4(92.3) 0.06
Haematocrit
0.37-0.47 0.41(0.003) 0.42(0.004) 0.13
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Appendix C
Forms and documents relating to the study
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SUBJECT INFORMATION SHEET
OCULAR BLOOD FLOW IN OCULAR HYPERTENSION AND
PRIMARY OPEN ANGLE GLAUCOMA . THE EFFECT OF TREATMENT
Glaucoma is generally associated with raised pressure in the eyes. However
there are a number of people with raised pressure who do not suffer from
glaucoma and never develop damage to the nerve of sight (optic nerve). This group
of people are called "ocular hypertensives" and a slightly high pressure is normal
for them. In this group there is a small number of people who are at risk of
developing glaucoma.At present there is no way of telling which people are
healthy ocular hypertensives at no risk of glaucoma and which people are likely to
develop the disease. It is possible that if the people at risk of developing glaucoma
could be identified and started on treatment to lower the pressure in their eyes
damage to their sight from glaucoma may be reduced or avoided.
Recent research has suggested that faulty blood flow to the back of the eye
may play a role in producing damage to the optic nerve in glaucoma. We can now
get detailed information about the blood flow to the eye using ultrasound. This is a
painless, entirely safe method of investigation which has been in use for many
years. It uses sound waves to "look" at blood flow. In this study we will be using
ultrasound and other tests to look at factors affecting blood flow to the eyes. We
hope to identify abnormalities in glaucoma patients which are also present in those
ocular hypertensives at risk of developing glaucoma allowing early identification
and treatment of this group.
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We have three main objectives;
Firstly to compare people with normal eye pressure with people who have
glaucoma.
Secondly to look at ocular hypertensives to see whether it is possible to identify
those people who may develop glaucoma. It may be that these people have a
similar blood flow pattern to people with established glaucoma.
Thirdly we will ask people diagnosed as having glaucoma to come back for repeat
tests 3 months after they have started their treatment to see whether the treatment
has any effect on bloodflow in addition to lowering the eye pressure.
If you agree to take part in this study you will be asked to come to the Eye
Pavilion for one day from 9am to 4pm (two separate days if you have glaucoma). In
addition to the bloodflow test on the eyes we will also measure the blood flow in
your hand and will take some photographs of the back of your eyes. We will take a
blood sample from your arm to check for the levels of several substances which can
alter bloodflow. During the day the pressure in your eyes will be checked at regular
intervals. There is no surgery involved in this study and the only procedure which
you may find uncomfortable is the blood test.
We would be very grateful if you would agree to take part. The study will
involve 150 people; 90 ocular hypertensives, 30 people with glaucoma and 30
healthy volunteers with normal eye pressure. Clinical data relating to you will be
held in strict confidence and your name and other identifiable particulars will not
appear in any report.
Your General Practitioner will be informed about your participation in this study if
you agree to take part.
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The doctor involved with the study will discuss it with you in detail and you
are free to ask any questions prior to taking part. Unfortunately we are not able to
give you travelling expenses unless without this help you would be unable to take
part in the study.
Participation in this study is entirely voluntary and if you do not wish to take
part or wish to withdraw while taking part, you may do so without giving any
explanation and also without in any way affecting your usual standard of care.
The main doctor involved in this study is Dr Jan Kerr and she will be
supervised by consultant surgeon Dr Colm O'Brien. If there are any points you wish
to discuss or any further questions please do not hesitate to contact Dr Kerr at the




Ocular Blood Flow in Ocular Hypertensives
and Primary Open Angle Glaucoma.
The Effect of Treatment.
Subject number
SUBJECT INFORMED CONSENT
I understand what I have been
told by Dr about the above study. I have read and
understood the Subject Information Sheet about this study (a copy of which has
been given to me) and have had the chance to ask any questions about it. I
understand and accept the answers that were given. I confirm that I have been
given time to think about and have freely agreed to participate in this study.
I know that I can at any time;
a. ask for more information from the doctor and
b. stop taking part in this study without this affecting my usual medical care
in any way.
I also know that if I wish to stop taking part in this study I do not need to give any
reason.
I agree to my General Practitioner being informed about my taking part in this study
as well as him being asked about my present and / or past illness and treatment.
I confirm that I have told the responsible doctor about all known past illnesses,
operations and medication.
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Ocular bloodfiow in ocular hypertensives
and primary open angle glaucoma. The effect of treatment.
Complete if the patient is providing written informed consent.




I, being the undersigned research doctor, confirm that I have fully explained
the nature and purpose of the study to the above patient and that he / she has read
and kept a copy of the Subject Information Sheet. He / she has freely agreed to
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